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The suckling period of rodents is accompanied by marked ketosis as a result of the high 
fat content of maternal milk. During this time, ketone bodies are the major source of 
energy for the brain. After weaning when the diet is mainly composed of carbohydrates, 
glucose becomes the major fuel for the brain. Here we could show that rearing mice on 
a ketogenic diet (KD) prolongs the metabolic state of ketosis in the brain seen during 
suckling. Reduced blood glucose concentration and increased ß-hydroxybutyrate levels 
are characteristic for KD fed animals, thereby reflecting the metabolic situation of the 
neonatal period. Inducing altered substrate availability by KD resulted in increased 
expression of monocarboxylate transporter 1 (MCT1) in cortical tissue as well as 
increased abundance of the key ketolytic enzyme Succinyl-CoA:3-oxoacid-CoA 
transferase (SCOT). However, detailed mechanistical insight in vivo is lacking and 
studies did not take into account cell type specific adaptations. We therefore established 
a refined protocol of MACS-technology, enabling isolation of highly pure cell fractions 
from individual cortices of adult animals. By using proteomic or transcriptomic analysis 
of astrocytes, oligodendrocytes, endothelial cells and neurons, cell type specific 
metabolic adaptations in response to KD feeding were analyzed. Surprisingly, our data 
indicate that endothelial cells under ketosis support brain metabolism through transport 
of ketone bodies while they rely on glycolysis. In contrast, astrocytes shifted their 
metabolism from glucose utilization to ketolysis and ß-oxidation thereby probably sparing 
glucose for neurons. Of note, oligodendrocytes largely remain metabolically unaltered 
and seem to support neuronal activity enhanced potassium buffering and potentially 
transport of ketone bodies. Interestingly, in addition to increased ketolysis neurons 
upregulated glycolytic enzymes. We speculate that increased utilization of KB and 
glucose leads to enhanced mitochondrial respiration. In turn, we hypothesize that 
enhanced mitochondrial respiration might support increased synaptic transmission in 
neurons and motor activity observed in KD fed mice. Taken together, our data highlight 
the compartmentalization of brain metabolism in different cell types under ketogenic 
conditions. Furthermore, these findings might build the basis to understand therapeutical 








1.1 Central nervous system 
The central nervous system (CNS), comprised of the brain and spinal cord, represent 
the control center of all vertebrates. Through its interconnection with peripheral organs, 
the CNS enables the organism to receive signals from the periphery, to process 
information and to trigger actions accordingly. It recognizes stimuli from the extremities 
(e.g. temperature, scents, feelings), manages body movements and inevitably sustains 
functionality of the body. In higher mammals the CNS constitutes the basis of 
superordinated functions like emotion, cognition, rational thinking and other more 
complex brain functions (Purves et al., 2004). To accomplish such a complex task, the 
brain is comprised of different specialized cells. Neurons, with their processes and 
especially their elongated axons, are well equipped for fast impulse propagation and 
information processing. To support neuronal functioning and to increase the speed of 
signal transduction, glial cells comprised of oligodendrocytes, astrocytes and microglia, 
evolved over time. It has been shown, that these glial cells, first considered as simple 
“glue” that holds neurons together (Virchow, 1854) are indispensable for proper brain 
function. Oligodendrocytes form myelin sheaths that enwrap axons, an event that is 
called myelination, to form internodes that restrict action potentials to the nodes of 
Ranvier. The lipid-rich myelin insulates axons and leads to increased trans-fiber 
resistance thereby creating the basis for fast saltatory nerve conduction (Baumann & 
Pham-Dinh, 2001; Kettenmann & Ransom, 2005). In addition to insulating axons, 
oligodendrocytes also control ion homeostasis due to their close contact with axons 
(Kamasawa et al., 2005; Larson et al., 2018) and support them with metabolites (e.g. 
lactate) (Funfschilling et al., 2012). However, especially for astrocytes it is known that 
these cells supply energy for neurons. These stellate cells are ideally positioned to 
distribute nutrients within the brain, due to their near complete coverage of blood vessels 
in the CNS (Cancilla et al., 1972; Kacem et al., 1998) and forming contacts with 
oligodendrocytes and especially neurons. It has been shown that glycolytic astrocytes 
support axons and synapses with nutrients like lactate during phases of increased 
activity (Pellerin & Magistretti, 1994; Supplie et al., 2017). Additionally, they are also 
essentially involved in transmitter clearing from the synaptic cleft thereby modulating 
synaptic transmission (Araque et al., 1998). Furthermore, astrocytes contribute to the 
formation of the blood-brain barrier (BBB), a unique structure of the brain mainly formed 
by endothelial cells to control the flux of metabolites from the blood stream to brain 
parenchyma and prevent the entry of unintended substances or pathogens. A hallmark 




uncontrolled transport of substances (Abbott et al., 2010). However, if a pathogen 
nonetheless enters the CNS, microglia as immune cells of the brain are activated to 
remove these pathogens by their phagocytic functions (Kettenmann & Ransom, 2005; 
Ransohoff & Cardona, 2010). The tight interplay between all brain cells enables the CNS 
to carry out all its important functions. To sustain constant functionality of the system an 
immense amount of metabolites is required to provide energy for the cellular machinery. 
 
1.2 Brain metabolism 
Despite the fact, that the human brain only accounts for approximately 2% of the body 
weight, 20% of the energy produced within the body is consumed by cells of the CNS 
(Erbslöh et al., 1958). Among these cells, neurons are believed to have the highest 
energy demand, due to synaptic transmission and maintenance of ion gradients needed 
for production of action potentials (Howarth et al., 2012). Glucose is assumed as the 
major energetic source for the adult brain to fuel energy consumption by its oxidative 
metabolism (Sokoloff et al., 1977).  
 
1.2.1 Glucose metabolism 
Within the CNS, energy requirements are mainly accomplished by utilization of glucose 
that is also used for generation of neurotransmitters and sustaining cellular homeostasis 
(Mergenthaler et al., 2013). To facilitate constant supply of glucose from the blood 
stream, glucose transporters (GLUTs) are expressed by endothelial and brain cells. 
GLUT1 (encoded by Solute carrier family 2 member 1; Slc2a1) the major glucose 
transporter of the brain, predominantly expressed in brain endothelial cells, mediates the 
entry of glucose into the extracellular fluid and the subsequent uptake into astrocytes, 
oligodendrocytes and microglia (Vannucci, 1994). GLUT3 (encoded by Slc2a3) is 
specifically expressed in neurons and ensures sufficient supply of glucose for neurons 
even under low glucose conditions due to its higher affinity and transport capacity 
compared to GLUT1 (Simpson et al., 2008). In general, it is suggested that glucose is 
mainly taken up by astrocytes and is shuttled to neurons directly or after conversion to 
lactate to support neuronal activity (Pellerin & Magistretti, 1994; Rouach et al., 2008). In 
addition, it was shown that oligodendrocytes like astrocytes are capable of producing 
lactate to support axons (Funfschilling et al., 2012). The so called “lactate shuttle”, first 
described by Pellerin and Magistretti in 1994 (Fig. 1), couples the transport of astroglial 
derived lactate to neuronal activity. However, experiments predict also simple diffusion 
to neurons bypassing the intracellular astrocytic transport (Simpson et al., 2007). Once 





phosphate (G6P) thereby trapping the molecule in the cell. G6P is metabolized via 
glycolysis to form pyruvate and lactate, which is then in turn transported into 
mitochondria to be used for ATP generation. Additionally, in astrocytes G6P is used to 
form glycogen (Cataldo & Broadwell, 1986), the only energy reservoir of the brain. G6P 
is also used by brain cells as substrate for the pentose-phosphate pathway (PPP) 
generating the reducing equivalent NADPH to control oxidative stress and to produce 
precursors for nucleic acid synthesis (Stincone et al., 2015). Within mitochondria, 
pyruvate is converted to acetyl-CoA by the pyruvate dehydrogenase complex. Acetyl-
CoA is then inserted into the tricarboxylic acid cycle (TCA) that is coupled to oxidative 
phosphorylation (OxPhos) to produce energy in form of ATP. 
The transport of neurotransmitter from blood to brain is highly restricted due to action of 
the BBB. Therefore, neuromodulators have to be produced endogenously from 
intermediates derived during glycolysis or PPP. In this regard, glucose is required as 
carbon donor for the biosynthesis of complex carbohydrates incorporated into 
glycoproteins and glycolipids, the construction of amino acids and monosaccharides, 
which are essential for functional neurotransmission (Dienel, 2012; Mergenthaler et al., 
 
Fig. 1: The astrocyte-neuron lactate shuttle hypothesis 
Glucose is taken up by astrocytic endfeed via glucose transporter 1 (GLUT1) and utilized to 
produce pyruvate and lactate, respectively by lactate dehydrogenase isoenzyme A (LDHA). 
Upon stimulation of astrocytes via glutamate uptake by glutamate transporters (GLT1) lactate 
can be shuttled to neurons via monocarboxylate transporters 1, 2 and 4 (MCT1/2/4). 
Reconversion of lactate into pyruvate via LDHB fuels oxidative phosphorylation within 
mitochondria. In addition, glucose can also enter neurons via GLUT3. Taken from (Newington 




2013). To summarize, glucose is essential to maintain brain function, either as substrate 
for biosynthetic processes or as energy supplier.  
 
1.2.2 Fatty acids as alternative fuel for the brain 
Undoubtedly, glucose is the preferred energy source for the brain, but also other 
metabolites contribute in smaller proportions to brain metabolism. Studies using isotopic 
labeled fatty acids revealed that ß-oxidation can account for approximately 20% of total 
brain energy production in rats (Ebert et al., 2003). Back in 1969 it could already be 
shown that fatty acids are transported into the brain (Dhopeshwarkar & Mead, 1969), but 
mechanisms facilitating the uptake of fatty acids are still a matter of debate.  
Currently two possible hypotheses exist that can act in concert by which fatty acids could 
enter the brain. On the one hand, fatty acids could cross the endothelial membrane by 
simple diffusion, independent of transport proteins, using a so called “flip-flop” 
mechanism (J. A. Hamilton, 2007). On the other hand, selective transport of fatty acids 
could be facilitated by specific transport proteins present at the cell membrane as well 
as intracellularly (Schwenk et al., 2010; Storch & Corsico, 2008) (Fig. 2). The most 
important members of fatty acid transport proteins are comprised of fatty acid transport 
proteins (FATPs), fatty acid translocase/CD36 (FAT/CD36), intracellular fatty acid 
binding proteins (FABPs) and long-chain fatty acyl-CoA synthetases (ACSL) (Doege & 
Stahl, 2006; Glatz & van der Vusse, 1996; Schaffer, 2002; Schaffer & Lodish, 1994; 
Stremmel et al., 1985). Among these, FATP-1 and FATP-4 seem to be the predominant 
fatty acid transporters expressed at the BBB of mice (Hirsch et al., 1998; Mitchell & 
Hatch, 2011), as well as FABP5 (Mitchell et al., 2011) and FAT/CD36 that has been 
shown to be involved in oleate transport (Mitchell et al., 2009). Knockdown of these 
transporters significantly reduced the transport of different fatty acids across human brain 
microvessel endothelial cells, indicating active transport of various fatty acids (Mitchell 
et al., 2011). In contrast, docosahexaenoic and eicosapentaenoic acid likely cross the 
BBB via diffusion (Ouellet et al., 2009). This is further supported by studies using 
CD36(- /-) mice. Experiments showed that incorporation of monounsaturated acids into 
phospholipids was decreased in CD36(-/-) mice, but polyunsaturated fatty acids like 
arachidonic and docosahexaenoic acid were incorporated into brain phospholipids at 
normal levels (Song et al., 2010). Since fatty acids are variable in chain length and their 
degree of saturation, it is very likely that different mechanisms are in place to mediate 







Following transport, fatty acids are metabolized via ß-oxidation to produce energy. 
Astrocytes are thought to be the major cell type in the brain capable of metabolizing fatty 
acids (Edmond et al., 1987; Romano et al., 2017). Prior to their degradation, fatty acids 
need to be activated for transport into mitochondria. Fatty acyl-CoA synthetase converts 
long-chain fatty acids to acyl-CoA thioesters, which then can be transferred to carnitine. 
Since CoA is unable to cross the mitochondrial membrane carnitine needs to be added 
to the acyl-CoA thioester. Carnitine palmitoyltransferase 1 (CPT1) catalyzes the rate 
limiting step in ß-oxidation by conversion of long-chain acyl-CoA to long-chain 
acylcarnitine (Lopaschuk et al., 2010; Schulz, 2002), thereby enabling the transport of 
fatty acids into mitochondria. Oxidation of fatty acyl-CoA thioester is carried out within 
 
Fig. 2: Free fatty acid uptake 
Free fatty acids (FFA) generated from lipoproteins within serum are mainly bound to albumin. 
Transport across the plasma membrane can occur via different transport proteins and 
mechanisms. FFA can directly interact with fatty acid transport proteins (FATP) facilitating the 
transport of FFA across the plasma membrane or by previous binding to fatty acid translocase 
(CD36). Long-chain fatty acyl-CoA synthetases (ACSLs) might facilitate activation of FFAs by 
its conversion to acyl-CoA after entering the cytosol. Fatty acid binding proteins (FABPs) or 
acyl-CoA binding proteins (ACBPs) further facilitate intracellular transport of FFAs. Passive 
diffusion by FFAs is also a possible mechanism by which FFAs can cross the cell membrane. 
Within the cell FFAs can be used for membrane synthesis or utilized via ß-oxidation. Adapted 




mitochondria in a repeated sequence comprised of four steps. The successive action of 
the main ß-oxidizing enzymes leads to the formation of one acetyl-CoA per cycle, 
shortening the acyl-CoA molecule until complete oxidation (Schulz, 2002). 
CPT1 can be allosterically inhibited by malonyl-CoA to prohibit vicious cycles between 
fatty acid synthesis and degradation (McGarry & Brown, 1997). Malonyl-CoA is produced 
from acetyl-CoA by the cytosolic enzyme acetyl-CoA carboxylase (ACC), which 
accomplishes the rate-limiting step in fatty acid synthesis (Awan & Saggerson, 1993). In 
turn, malonyl-CoA can be degraded by malonyl-CoA decarboxylase (MCD, encoded by 
Mlycd) (Dyck et al., 1998). Consequently, ß-oxidation is controlled by the precisely 
balanced synthesis and degradation of malonyl-CoA.  
 
1.2.3 Ketone body synthesis and utilization 
Besides their direct utilization within the brain, fatty acids can support brain metabolism 
indirectly via production of ketone bodies. Under specific physiological conditions, the 
liver is essentially involved in the production of ketone bodies (KB) by using fatty acid 
derived acetyl-CoA as substrate. No other metabolite class is able to replace glucose to 
the same extent as brain energy source as ketone bodies can.  
The term KB summarize the three metabolites ß-hydroxybutyrate (ßOHB), acetoacetate 
(AcAc) and to a minor portion acetone, which is spontaneously formed from AcAc. KB 
can meet the energetic needs of the brain to nearly 70% under starvation in humans 
(Cahill, 2006; Owen, 2005) or during the suckling period in rats (Nehlig, 2004). 
Ketogenesis occurs mainly in the liver by using Acetyl-CoA as substrate when fatty acid 
availability is high such as during fasting/starvation, post-exercise, the neonatal period 
or by adhering to a ketogenic diet. ß-oxidation derived acetyl-CoA is condensed to 
acetoacetyl-CoA (AcAc-CoA) via a thiolase (Fig. 3). Mitochondrial 3-
hydroxymethylglutaryl-CoA synthase (HMGCS2) catalyzes the rate-limiting step by 
condensation of AcAc-CoA and acetyl-CoA leading to the formation of 
hydroxymethylglutaryl (HMG)-CoA. HMG-CoA lyase (HMGCL) cleaves HMG-CoA to 
release AcAc, which is reduced to ßOHB by ßOHB dehydrogenase 1 (BDH1) (Grabacka 
et al., 2016; Puchalska & Crawford, 2017). AcAc and ßOHB are then released into the 
circulation and transported into extrahepatic tissues such as brain, heart or muscle for 
oxidation (Cotter et al., 2011). Monocarboxylate transporters (MCTs) facilitate the 





Once within the brain, KB utilization takes place in mitochondria. BDH1 catalyzes the 
first reaction of ketolysis by oxidation of ßOHB to generate AcAc (Lehninger et al., 1960). 
Oxidation of AcAc to AcAc-CoA is facilitated by the rate-limiting enzyme Succinyl-CoA:3-
oxoacid-CoA transferase (SCOT; encoded by 3-Oxoacid CoA-Transferase 1, Oxct1) 
through exchange of CoA from succinyl-CoA to AcAc (Cotter et al., 2011). SCOT is not 
expressed in liver, avoiding futile cycling between synthesis and breakdown of KB (Orii 
et al., 2008). Breakdown of AcAc, which is mediated by acetyl-CoA acetyltransferase 1 
(ACAT1) produces two molecules acetyl-CoA, which are fueled into the TCA cycle for 
production of ATP (Fig. 3). 
Next to the energy producing oxidation, KB can be used as precursors for anabolic 
pathways in the cytosol. Here, cytoplasmic acetoacetyl-CoA synthetase (AACS) 
facilitates the ATP-dependent conversion of AcAc to AcAc-CoA that in turn can be 
directed towards sterol biosynthesis. Cytosolic HMGCS1 catalyzes the first step of 
cholesterol synthesis to form cytosolic HMG-CoA from AcAc-CoA and acetyl-CoA. 
 
Fig. 3: Ketone body metabolism 
When fatty acids are available in excess amounts in the circulation and glucose is in short 
supply, they undergo ß-oxidation in the liver resulting in the formation of acetyl-CoA that serves 
as substrate for ketogenesis. HMGCS2 catalyzes the rate-limiting step of ketogenesis leading 
to the production of AcAc and ßOHB. These KB are released into the circulation and can be 
taken up via MCT1 into the brain. Herein KB can undergo ketolysis in mitochondria to produce 
acetyl-CoA that is inserted into the TCA cycle to produce energy. SCOT facilitates the rate-
limiting step of ketolysis by conversion of AcAc to AcAc-CoA. Within the cytosol, KB can also 
be used as precursor for cholesterol and fatty acid synthesis. AACS converts AcAc to AcAc-
CoA that is further processed. Resulting Acetyl-CoA derived from AcAc can be used by 
HMGCS1 to direct it to sterol synthesis, which is controlled byHMGCR. In addition, cytosolic 
acetyl-CoA can also be directed to fatty acid synthesis by the rate-limiting enzymes ACC1/2. 




Subsequently, HMG-CoA reductase (HMGCR) conducts the rate-limiting step of sterol 
synthesis by production of mevalonate. However, AcAc-CoA can also be cleaved to 
generate acetyl-CoA that is needed for synthesis of fatty acids by acetyl-CoA 
carboxylase 1 and 2 (ACC1/2, encoded by Acaca and Acacb) (Fig. 3). Especially during 
the neonatal period in rodents, the use of KB as energy source but also as precursor for 
lipidogenesis and cholesterogenesis is crucial for maintaining brain development 
(Bergstrom et al., 1984; Edmond, 1974; Webber & Edmond, 1979). 
  
1.3 KB during suckling and the metabolic switch upon weaning 
It has been known for decades, that the suckling period of rodents is accompanied by 
marked ketosis due to the high fat content of maternal milk (Czajka et al., 1964). During 
this time levels of KB range between 1 and 2 mM in the blood stream (E. Bailey & 
Lockwood, 1971; Hawkins et al., 1971). Interestingly, despite sufficient circulating 
amounts of glucose, the brain of suckling rodents might not be able to use glucose very 
efficiently as energy source since glycolytic enzymes are low expressed at this time 
(Booth et al., 1980; Gaitonde & Richter, 1966; Moore et al., 1971). In contrast, the 
immature brain is well equipped to utilize KB for energy production and biosynthesis of 
lipids and sterols. Sufficient cerebral KB metabolism dependents on three different 
aspects: (1) KB concentration within blood, (2) expression of transporters, (3) activity 
and expression of ketolytic enzymes. The uptake of KB by the brain directly relates to 
the circulating concentration of AcAc and ßOHB (Morris, 2005), but the brain of suckling 
rats is able to oxidize KB at higher rates than the mature brain at a given arterial 
concentration (Schroeder et al., 1991). Since KB level in blood of suckling rats is already 
high, the cerebral KB metabolism is further increased. In addition to KB concentrations 
in the circulation, KB metabolism in the brain is regulated by the abundance of MCTs 
within the BBB (Morris, 2005). MCT1 (encoded by Solute carrier family 16 member 1; 
Slc16a1) is mainly expressed by endothelial cells (Gerhart et al., 1997) while MCT2 
(encoded by Slc16a7) has been related to neurons (Pellerin et al., 1998) and MCT4 
(encoded by Slc16a3) might be astrocyte specific (Bergersen et al., 2001). In particular, 
the expression of MCT1 is significantly higher expressed in endothelial cells and 
astrocytes during suckling compared to adult conditions (Leino et al., 1999). Therefore, 
the transport capacity of ßOHB across the BBB is high during the suckling period, but 
declines drastically during adulthood (Cremer, 1982; Daniel et al., 1977) (Fig. 4). 
Following transport of KB into the brain, the ketolytic capacity therein is directly 
proportional to the activity and expression of SCOT (Orii et al., 2008) the rate-limiting 
enzyme of ketolysis. During the postnatal development, ketolytic enzymes are increased 





revealed that SCOT activity within the immature rat brain reaches maximal levels at 
approximately postnatal day 20 (P20), drastically declining afterwards to reach low adult 
levels (Krebs et al., 1971; Page et al., 1971) (Fig. 5A).  
 
Similar results have been observed for BDH1 (Krebs et al., 1971; Leong & Clark, 1984). 
Only ACAT1 shows a somewhat different activity pattern during the postnatal period. 
Already maximal at birth, ACAT1 activity remains constantly high until P30 but decreases 
later on by 40% to reach adult levels (DeVivo et al., 1976; Krebs et al., 1971). ACAT1 
might be used additionally in isoleucine breakdown (Su et al., 2017), which could explain 
the already high activity seen at birth. The developmental pattern of activity and 
expression of KB transporters and ketolytic enzymes seem to be well orchestrated by 
the increased KB availability in the circulation during suckling. When mice and rats are 
weaned at around P21 levels of ßOHB and AcAc decline to reach adult levels, which 
normally range between 0.2 and 0.5 mM in blood (E. Bailey & Lockwood, 1971). This 
might reflect the switch of suckling rodents from ingestion of maternal milk to 
carbohydrate rich chow. As a result, cerebral uptake of KB decreases with a concomitant 
increase in utilization of glucose (Nehlig & Pereira de Vasconcelos, 1993) (Fig. 4). In 
fact, development of brain glucose metabolism is contrasting cerebral KB metabolism. 
While expression of MCTs is highest during the first weeks of age, GLUT1 and GLUT3 
reach their highest levels at around P30 (Vannucci, 1994). In addition, activity of the 
 
Fig. 4: Cerebral glucose and ßOHB utilization 
Color-coded autoradiographic representation of the postnatal time course of glucose utilization 
and rates of cerebral ßOHB uptake in rat brain sections. The color scale at the bottom depicts 
quantitative rates of glucose utilization or ßOHB uptake. Black and blue indicate low rates, 
green medium rates and yellow to red high rates of utilization or uptake. Note that while glucose 
utilization is low during the first three weeks of postnatal development it starts to increase after 
weaning at PN21. In contrast, ßOHB uptake is highest during the suckling period and declines 




major glycolytic enzymes reach maximal levels at weaning, when rodents start to ingest 
carbohydrate rich chow (Booth et al., 1980). This metabolic switch occurs during weaning 
and coincides with the peak of myelination, for which KB might serve as important 
substrates (Fig. 5B). 
 
1.3.1 KB as precursor for lipid and sterol synthesis during myelination 
In the brain, the amount of fatty acids and sterols increases about 4-fold during suckling 
until adulthood (Edmond et al., 1998; Nehlig, 2004). It has been shown that the increase 
in fatty acids and sterols is mainly attributable to de novo synthesis (Edmond et al., 1998). 
As consequence, the brain is dependent on precursors for fatty acid synthesis important 
for myelination. ßOHB and AcAc have been shown to be suitable substrates for the 
synthesis of fatty acids and cholesterol (Edmond, 1974; Lopes-Cardozo & Klein, 1985) 
and are even preferentially used over glucose (Koper et al., 1981). AcAc seem to be the 
major substrate for lipid synthesis. The rate of fatty acid synthesis from AcAc increases 
until P5 declines rapidly during the residual suckling period, but still exceeds the rate of 
fatty acid synthesis of ßOHB (Yeh et al., 1977). However, others reported that ßOHB is 
the preferred substrate for lipid biosynthesis at later stages (i.e. P9-12 and P18) 
(Edmond, 1974; Webber & Edmond, 1979). Nonetheless, KB are important substrates 
for cholesterol synthesis to facilitate myelination and brain growth during the neonatal 
period. Indeed, during adulthood, KB are virtually not incorporated into lipids or proteins, 
but might exclusively be used for oxidation (Lopes-Cardozo & Klein, 1985). In rats, active 
 
Fig. 5: Developmental course of SCOT activity and myelination 
(A) Activity of SCOT in brain during postnatal development of the rat. Maximal activity is 
observed at around P20, after which it declines to adult levels (broken line with vertical bar). 
Taken from (Page et al., 1971). (B) Accumulation of myelin content within the brain during 
postnatal development in the rat (left ordinate, circles). Rate of myelin accumulation is plotted 






myelination is considered to start around P10 in rats (Edmond et al., 1998; Norton & 
Poduslo, 1973) and reaches its highest rate at P20 (Norton & Poduslo, 1973) (Fig. 5B). 
Despite the fact that at this age only 15% of the total adult myelin content is synthesized, 
the rate of myelin synthesis decreases sharply (Norton & Poduslo, 1973). These findings 
highlight the importance of KB as source for myelin cholesterol due to the fact that the 
rate of fatty acid and cholesterol synthesis decreases when glucose is used as energy 
source.  
 
1.4 The ketogenic diet and its potential mechanisms for 
treating neurological disorders 
Ketogenic diet (KD) is a high fat, low carbohydrate diet with a fat-to-carbohydrate plus 
protein ratio of 4:1, resulting in over 90% of metabolizable energy from fat with residual 
calorie intake from protein and carbohydrates (Gano et al., 2014; Kossoff & Rho, 2009). 
As hallmark of the KD, production of KB is observed with concurrent reduction in glucose 
availability (Gano et al., 2014) resembling the metabolic state seen during suckling. 
Discovered almost a century ago, anticonvulsive properties were linked to fasting 
(Lennox & Cobb, 1928)  and feeding a KD replicated this metabolic effect but at the same 
time allows sufficient calorie intake and preserves endogenous lipid stores (Clanton et 
al., 2017; Wheless, 2008). The KD became the treatment of choice for epilepsy, but fell 
out of focus after the development of the first anti-seizure drugs in 1938 (Bailey et al., 
2005). During the past 20 years interest returned after recognition that the KD was able 
to treat pharmacoresistant forms of epilepsy especially in children (Freeman & Vining, 
1999; Neal et al., 2008). Additionally, extensive research indicated that the effectiveness 
of a KD is not restricted to treating epilepsy. The KD exhibits beneficial effects for treating 
models of neurological disorders such as brain cancer (Abdelwahab et al., 2012), 
Alzheimer, Parkinson and Huntington disease (Henderson, 2008; Lim et al., 2011; 
Vanitallie et al., 2005), amyotrophic lateral sclerosis (Zhao et al., 2006) and very recently 
in a mouse model of the hereditary leukodystrophy Pelizaeus-Merzbacher disease 
(Stumpf et al., 2019). The broad anticonvulsant spectrum of the KD might be attributable 
to the plethora of possible mechanisms by which the KD influences brain metabolism, 
neurotransmitter release/synthesis and mitochondrial biogenesis. 
 
1.4.1 Proposed anticonvulsant effects of the ketogenic diet 
Epilepsy describes states of spontaneously synchronized depolarization of neurons 
leading to situations of unawareness, unconsciousness and uncontrolled motor activity 





Table 1: potential beneficial effects of the ketogenic diet 
 
Such seizures could be reduced in 75% of patients, who adhered to the KD over a three-
months period (Neal et al., 2008). It is hypothesized that the KD induces anti-seizure 
effects by increasing KB level. AcAc has been found to reduce neuronal hyperexcitability 
by inhibition of glutamate release (Table 1) as it is the major excitatory neurotransmitter 
(Koppel & Swerdlow, 2018). Another possible mechanism by which the KD could 
influence neuronal excitability involves direct changes in levels of glutamate and its 
counterpart γ-ammino butyric acid (GABA). Through anaplerosis the KD increases the 
need of oxaloacetate to condense with acetyl-CoA, thereby reducing the production of 
aspartate from glutamate and favoring the synthesis of GABA through glutamate 
decarboxylase (Gano et al., 2014; Yudkoff et al., 2005). In turn, increased GABA levels 
could lead to enhanced inhibitory neurotransmission (Yudkoff et al., 2005). Indeed, 
changes in brain neurotransmitter levels were found to be altered upon KD ingestion, but 
obtained results are inconsistent. Nonetheless, a shift of the balance between these 
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Since application of the KD increases ATP levels (DeVivo et al., 1978; Kim et al., 2010) 
it was proposed that the KD ultimately leads to increased adenosine levels (Maalouf et 
al., 2009) (Table 1). Adenosine is thought to modulate antiseizure effects by activation 
of adenosine A1 receptors (A1Rs) leading to inhibition of excitatory neurons (Masino et 
al., 2012; Rogawski et al., 2016). 
 One hallmark of the KD is a reduction of blood glucose levels through reduction of 
carbohydrates by the diet. Since KB level does not necessarily correlate with levels of 
seizure control, it was hypothesized that decreased glucose metabolism may be 
important for seizure prevention (Lutas & Yellen, 2013). Best evidence supporting this 
assumption is the observation that seizure control can be rapidly reversed after ingestion 
of carbohydrates (Huttenlocher, 1976). However, mechanisms by which glucose 
reduction leads to decreased hyperexcitability remain unknown. In regard of glucose 
reduction, the KD gained interest in treating brain cancer. As cancer cells are mainly 
dependent on glycolysis and lactate production without relying on oxidative 
phosphorylation, a process known as “Warburg effect”, the KD is a suitable tool to 
withdraw these cells their metabolic basis. Indeed, the KD has been shown to be an 
effective alternative therapy for treating malignant glioma (Abdelwahab et al., 2012; Zhou 
et al., 2007). 
 
Fig. 6: Possible mechanism of the ketogenic diet leading to neuroprotection 
The KD leads to metabolic changes (blue) enhancing KB level. KB might influence factors and 
mechanisms (green) resulting in anticonvulsant effects and metabolic improvements. As 
consequence, harmful processes are reduced whereas positive mechanism are enhanced 




Oxidative stress has been linked to the progression of multiple neurodegenerative 
diseases (Barnham et al., 2004). Several studies indicated that the KD might be able to 
decrease oxidative stress by enhancing antioxidant mechanisms (Table 1). Direct effects 
of the KD might be displayed by the scavenging potential of KB. ßOHB and AcAc have 
been shown to reduce numerous reactive oxygen species (ROS) in vitro, but only under 
unphysiological conditions (Haces et al., 2008). Another possibility by which the KD could 
decrease mitochondrial ROS production is the stimulation of ATP production through 
increased complex II flux of the electron transport chain (Ho et al., 2012). In turn, 
superoxide formation by complex I is potentially diminished. Thereby, the KD could be 
able to improve mitochondrial respiration and enhance energy production. 
In conclusion, the KD might exhibit multiple beneficial effects that could act in concert to 
modulate synaptic transmission and alter brain metabolism thereby ameliorating different 
symptoms of neurological disorders (Fig. 6).  
 
1.4.2 The KD’s potential in supporting myelination in neurodegenerative 
diseases 
In mice, developmental myelination is primarily ongoing between P10 and P60 in most 
brain regions (Baumann & Pham-Dinh, 2001). Myelination is carried out by 
oligodendrocytes to enable fast saltatory nerve conduction and axonal integrity (Nave & 
Werner, 2014). This process requires extensive formation of oligodendrocytic plasma 
membrane mostly comprised of lipids and sterols to enwrap and insulate axons. KB are 
the preferred substrate for cholesterol and lipid synthesis for myelination during 
development (Edmond, 1974; Yeh et al., 1977), raising the question of the KD’s potential 
to support remyelination in neurodegenerative diseases. However, direct evidence that 
the KD supports remyelination is scarce and only a few case studies support this 
hypothesis. Aspartate-glutamate carrier 1 (AGC1) is involved in the malate-aspartate 
shuttle (Falk et al., 2014), that facilitates neuronal export of glial aspartate important for 
proper myelination (Clanton et al., 2017). Deficiency of AGC1 causes infantile epilepsy 
and hypomyelination (Falk et al., 2014). Recently, in a patient with AGC1 deficiency, the 
KD improved psychomotor development and myelination measured by magnetic 
resonance spectroscopy (Dahlin et al., 2015) indicating potential effects in treating 
myelination defects. Similar improvements of myelination could be observed in a patient 
with GLUT1 deficiency adhering to the KD (Klepper et al., 2007) (Fig. 6). Very recently, 
a study using proteolipid protein 1 (PLP1) transgenic mice to model Pelizaeus-
Merzbacher disease, showed enhanced myelination when mice were treated with the 





authors speculated that the KD might enhance remyelination by supporting local 
cholesterol synthesis and enhances oligodendrocyte precursor cell proliferation.  
However, given the immense amount of possible mechanisms by which the KD modulate 
anticonvulsant effects, reduce oxidative stress and improve mitochondrial respiration, 





1.5 Aim of the study 
The KD is widely used to treat certain forms of epilepsy and is extensively studied for its 
potential to ameliorate neurodegenerative diseases such as Alzheimer or Parkinson 
disease. Studies investigating the KD’s beneficial effects revealed a plethora of potential 
mechanisms. However, evidence supporting the positive effects of the KD originate from 
experiments using cell culture, ex vivo slice experiments or global assessment of tissue 
changes. All of these have certain disadvantages with respect to analyzing the KD’s 
mechanism. In vitro or ex vivo studies use unphysiological concentrations of KB or 
artificial serum conditions not observed in vivo. Additionally, the contribution of the BBB 
and the adaptation of the brain to the peripheral metabolism cannot be attributed. On the 
other hand, in vivo studies draw their conclusion from global tissue changes lacking the 
cell type specific resolution needed to assess cell type specific adaptation. Furthermore, 
the influence of the KD on brain metabolism was often investigated under disease 
conditions that themselves can influence brain metabolism. Hence, cell type specific 
metabolic changes in vivo in response to feeding a KD under non disease conditions 
have not yet been studied to unravel actions of the KD on brain cell metabolism. 
 
Here, we aimed at testing the cell type specific metabolic changes of brain cells under 
physiological conditions in mice fed a KD. To address the question whether the metabolic 
switch seen upon weaning in the brain is due to endogenous signals or caused by dietary 
changes, mice were fed a KD for up to six weeks of age. Investigation of global metabolic 
changes within the brain by using immunoblot, fluorescent immunohistochemistry and 
ultrastructural analysis was used to select the age of mice where adaptation to ketosis 
is maximal.  
In depth analysis was performed at the time point with maximal effects to address the 
following questions: Which metabolic pathways will be altered in brain cells? Will they 
switch to KB utilization under low glucose conditions or rely on residual glucose? 
Furthermore, is it possible to draw conclusions in which way substrates are distributed 
among cell types under ketogenic conditions? 
Therefore, cell type specific isolation from adult mouse brain coupled to subsequent 
proteomic and transcriptomic analysis was performed to investigate cell type specific 
metabolic changes. This enabled comparison between cell types and helped to 






2.1 Experimental design 
During weaning the brain metabolism undergoes a rapid change that switches substrate 
preferences from ketone bodies (KB) to glucose (Nehlig, 2004). To test, if this metabolic 
switch of the brain can be prevented and to investigate the time course of metabolic 
events within the brain, mice were reared by a ketogenic diet (KD). To achieve a smooth 
transition from ingestion of mother’s milk to adhering to the KD, food was applied from 
two weeks of age onward, when pups still ingest milk. Application of the KD to the dam 
can cause severe ketoacidosis and prevent lactation (Sussman et al., 2013). To 
circumvent this issue, special rearing devices were developed to achieve food separation 
between mother and pups (Fig. 7A). Liquefied powdered chow was applied to the mother 
on a shelf that is not accessible for the pups. However, pups could reach the KD applied 
in a small box with holes, which were too small for the mother. Food for the mother was 
applied at P10 of the pups, whereas the food for the pups (either KD or standard diet) 
was applied at two weeks of age (Fig. 7B). Mice were weaned at P17 and fed the KD or 
standard diet (SD) for up to six weeks. The high fat content of the KD results in altered 
proportion of gained kcal from fat, protein and carbohydrates  (Fig. 7C). We speculated 
 
Fig. 7: Rearing device, investigation strategy and diet composition. 
(A) Rearing devices to achieve food separation between dams and pups. (B) Investigation 
strategy with indicated time points for food change for dams and weaning. Standard diet (SD) 
or ketogenic diet (KD) were applied from two weeks onward for pups. (C) Composition of 




that resulting ketosis will prolong the metabolism of mice seen during the suckling period 
due to reflections of mother’s milk.  
 
2.2 Blood level of mice react to rearing on a KD  
Due to the high fat content, the KD leads to hepatic production of KB that are released 
into the circulation increasing the concentration of ßOHB as major KB. In turn, glucose 
concentration decreases (Gano et al., 2014; Kossoff & Rho, 2009). Therefore, 
investigation of blood levels of ßOHB and glucose served to determine successful 
induction of ketosis through feeding a KD. After weaning, concentration of ßOHB 
increased significantly in mice fed the KD to reach maximal values at five weeks of age 
(Fig. 8A). In SD fed mice, concentration of ßOHB declined after weaning to reach adult 
levels in accordance with previous studies (E. Bailey & Lockwood, 1971; Hawkins et al., 
1971) and remained constant after three weeks of age. Glucose concentration inversely 
correlated with ßOHB levels in blood and decreased significantly in mice fed a KD 
compared after weaning. In contrast, SD fed mice showed increased glucose 
 
Fig. 8: Induction of ketosis upon feeding a ketogenic diet. 
Blood level of ßOHB (A) increase over time while Glucose (B) decreases when mice are fed a 
ketogenic diet. (C) Body weight in mice fed a ketogenic diet increase slower than mice fed a 
standard diet. Graphs represent mean values ± SEM of n=20 animals. Asterisks depict 
significant differences with *p<0.05, **p<0.005, ***p<0.001, ****p<0.0001 (two-way ANOVA 
with Sidak’s post test). (D) Brain weight of mice at six weeks of age is unaffected. Bars 
represent mean values with individual data points (n=12-13). Student’s t-test. SD= standard 





concentrations after starting to ingest the SD (Fig. 8B). Concentration of ßOHB and 
glucose seemed to stabilize at a certain level after four to five weeks of age in both 
groups. 
Ingestion of a KD is known to reduce body weight (Bergqvist, 2012; Thio et al., 2006). 
Therefore, gain of body weight of mice fed SD or KD was analyzed. KD mice steadily 
increased body weight over time but at a significantly slower rate than mice fed the SD 
(Fig. 8C). However, brain weight of KD fed mice was unaltered at six weeks of age (Fig. 
8D) suggesting normal brain growth. This finding is in line with previous results reporting 
stable brain volume of mice after three weeks of age (Hammelrath et al., 2016). Taken 
together, these results indicate successful induction of ketosis in KD mice after weaning. 
Furthermore, despite slower increase in body weight, brain growth is facilitated at normal 
levels in mice fed KD. 
 
2.3 Brain maturation of mice reared with a ketogenic diet 
Since mice reared on the KD exhibit reduced body growth, analysis of brain maturation 
was performed to investigate possible effects of the KD on brain development. Brain 
derived neurotrophic factor (BDNF) is considered as general maturation marker, as 
expression increases with brain maturation (Maisonpierre et al., 1990). Expression 
analysis of Bdnf in cortex of mice revealed no differences between dietary groups, 
suggesting normal brain maturation (Fig. 9A). In addition, expression of Myelin basic 
protein (Mbp), a mature myelin marker (Winters et al., 2011) showed no changes in 
expression at any investigated time point (Fig. 9B). However, expression of Myelin-
oligodendrocyte glycoprotein (Mog), a marker for oligodendrocyte maturation (Scolding 
et al., 1989), was slightly reduced at six weeks of age in cortex of KD mice indicating 
alterations of oligodendrocyte maturation (Fig. 9C). Nonetheless, these results indicate 





Fig. 9: Expression analysis of brain maturation marker 
(A-C) qRT-PCR analysis in cortex of mice fed KD or SD at indicated time points show no 
changes for the brain maturation marker Bdnf (A) and the mature myelin marker Mbp (B) but 
slight reduction of the oligodendrocyte maturation marker Mog at six weeks of age (C). Bars 
represent mean expression normalized to SD fed animals with individual data points (n=4-5). 
Asterisks depict significant differences with *p<0.05, (two-way ANOVA with Sidak’s post test). 
SD= standard diet; KD= ketogenic diet.  
 
2.4 Myelination is unaltered in mice reared with a ketogenic 
diet 
KB have been shown to be suitable substrates for the synthesis of fatty acids and 
cholesterol (Edmond, 1974; Lopes-Cardozo & Klein, 1985), thereby facilitating 
myelination. Since mRNA expression does not necessarily reflect protein abundances, 
myelination was analyzed on morphological level in response to the KD. Therefore, 
cortices of mice were investigated using electron microscopic analysis at six weeks of 
age. Fluorescent immunolabeling of MBP in sagittal sections of mice did not show 
alterations regarding MBP abundance in cortex of KD fed animals (Fig. 10A). MBP 
positive signal, reflecting myelinated fibers traversing throughout the cortex, was 
comparably present in mice of both dietary groups. This finding supported results from 
expression analysis suggesting no alterations in Mbp expression (compare Fig. 9B). 
However, ultrastructural differences of myelin or axon thickness still could be present. 
To address this issue, number of myelinated fibers and myelin thickness was assessed 






Fig. 10: Myelination remains unchanged when mice fed a ketogenic diet 
(A) Fluorescent staining of MBP in sagittal sections of mice fed SD or KD at six weeks of age 
reveals no obvious differences. Scale, 100µm. (B) Representative electron microscopic image 
in cortex of mice fed SD (left) or KD (right) at six weeks of age. Scale, 500nm. (C) G-ratio 
analysis of cortical axons and axon caliber distribution (D) shows no difference at six weeks of 
age (n=3). (E) G-ratio analysis of axons in optic nerve at three weeks of age. (F) Mean axon 
diameter in optic nerve at three weeks of age (n=3). One-way ANOVA with Sidak’s post test. 
SD= standard diet; KD= ketogenic diet. 
 
revealed normal appearance of myelinated fibers in cortex of KD fed mice (Fig. 10B). 
The g-ratio is a measurement to assess myelin thickness and hence sufficient insulation 
for proper conduction velocity (Waxman, 1980). It is calculated by division of axon 
diameter through the diameter of fiber plus surrounding myelin (Saher et al., 2012). 




10C), suggesting no alterations in myelin thickness. In addition, distribution of analyzed 
fibers did not differ between groups (SD: 107.67 ±8.37 SEM; KD: 121.67 ±6.90 SEM; 
p=0.389; two-sided Student’s t-test), further supporting normal myelination of axons 
within the cortex of KD fed mice. The diameter of axons is an important structural 
characteristic of the CNS and correlates with conduction velocity. In addition, it can be 
affected by neurological disorders (Sepehrband et al., 2016). Changes in the distribution 
of axon calibers could therefore indicate altered conduction velocity of axons. However, 
frequency distribution of axon calibers within the cortex of mice fed the KD did not show 
any signs of changed axon calibers (Fig. 10D). In summary, the current findings indicate 
normal myelination at six weeks of age within the cortex of ketogenic reared mice. 
Myelination was unaffected at six weeks of age in cortex of mice on KD. However, the 
KD could exhibit transient effects at earlier time points. To test this idea, myelination was 
assessed at three weeks of age within the optic nerve where rate of myelination is 
maximal (Dangata et al., 1996). Since myelin formation occurs in an eye-to-chiasm 
direction (Colello et al., 1995) g-ratio measurements were performed at the chiasmatic 
end of the nerve where possible effects would be most pronounced. However, g-ratio 
analysis did not reveal significant differences in myelin thickness in regard to axon 
diameter suggesting unaltered myelination at three weeks of age in KD fed mice (Fig. 
10E). Additionally, mean axon caliber in optic never showed no significant alterations in 
response to KD feeding (Fig. 10F) suggesting normal axon growth. Taken together, 
these results indicate that rearing mice on a KD does not alter myelination during highest 
rate of myelin formation. However, it has to be considered that the time of application of 
the KD might be too short to have influence on myelin formation. 
 
2.5 KD support normal development of cognition and learning 
in mice 
To analyze if the KD in mice could lead to altered cognition or learning ability we 
performed a sound discrimination experiment in collaboration with Dr. Livia de Hoz from 
the neurogenetics department of the Max-Plank Institute of Experimental Medicine. Mice 
at five weeks of age were placed into cages connected to an audiobox, a setup suitable 
to measure cognition and learning ability in mice (de Hoz et al., 2018; de Hoz & Nelken, 
2014). Mice can freely move within their home cage with access to food. Water is 
provided within the audiobox behind openable doors (Fig. 11A). To get access to water, 
mice need to perform nose poke to open the doors in front of the water bottles. Always 
when a mouse visits the audiobox, a specific sound is played. To test the ability of 





the habituation phase, mice always hear the “safe” sound (6.67 kHz) when entering the 
audiobox without consequences after nose poking. From day six of the experiment 
(training phase) at a certain percentage the “conditioned” sound (13.34 kHz) is played 
after a visit. Nose poking during a conditioned visit resulted in an aversive air puff and 
no access to water. Therefore, mice need to discriminate between a “safe” and 
“conditioned” sound and need to learn to avoid nose poking after a conditioned visit. 
During the whole experiment mice reared on the KD or SD had comparable number of 
visits per mouse per day (Fig. 11C). This suggests, that KD fed mice did not show any  
signs of fatigue or lack of motivation. Furthermore, this result confirms, that both dietary 
groups had comparable amount of visits to learn to avoid the conditioned sound. 
Evaluation of visits without a nose poke revealed that mice on SD or KD, respectively 
avoided nose poking in approximately 30-40% of the visits during the whole experiment 
when a “safe” sound is played with no significant difference between groups (Fig. 11D). 
 
Fig. 11: Ketogenic diet feeding does not impair learning ability 
(A) Schematic construction of the Audiobox. Mice can freely move within their home cage with 
access to food ad libitum. Mice need to nose poke to get access to water within the Audiobox 
while different sounds can be played. (B) Paradigm to test learning ability of mice. During the 
habituation phase mice hear the safe sound when entering the Audiobox and nose poking has 
no negative effect. At day 6-9 in indicated percentages a conditioned sound is played when 
mice visit the Audiobox. Nose poking after a conditioned visit leads to the application of an 
aversive air-puff and no access to water. Mice need to learn to avoid nose poking after hearing 
the conditioned sound. (C) Total number of visits between mice fed SD or KD during the 
experiment is not altered. (D) Percentage of visits without nose poke under safe and 
conditioned conditions for mice on KD or SD at five weeks of age reveal similar learning ability. 




At day 6 of the experiment, mice avoided nose poking after a conditioned sound in over 
50% and 65% of the visits for SD and KD fed mice, respectively. This percentage further 
improved during the following days to approximately 75-90% of the cases for both 
groups. No significant differences were detected at any time point between SD and KD 
fed mice, indicating normal learning curves between SD and KD fed mice. Taken 
together, these results indicate that mice are able to discriminate between different 
sounds and quickly learn to avoid the “conditioned” sound within one day. Furthermore, 
it supports the previous findings, that the KD in mice facilitate normal brain growth and 
development. Hence, apart from reducing body growth, no signs for reduced 
development within the brain was found.  
 
2.6 Glycolytic changes in cortex of mice fed KD 
The observed reduction in blood glucose could influence glucose metabolism within the 
brain. To address the question whether the KD would alter glycolysis in cortex of mice, 
qRT-PCR were performed for Glut1 and Hk1. Despite the observed reduction of glucose 
within the blood (compare Fig. 8B), expression of Glut1, the major glucose transporter 
within the brain (Vannucci, 1994), showed no significant decrease at six weeks of age 
upon feeding a KD (Fig. 12A). Expression of Hk1, the enzyme facilitating the first 
committed step of glycolysis, showed similar results (Fig. 12B). In previous studies 
results reported conflicting results for GLUT1 abundance upon feeding a KD ranging 
from decrease over no change to increased levels (Forero-Quintero et al., 2017; 
Hernandez et al., 2018; Leino et al., 2001). Therefore, we analyzed GLUT1 protein level 
in cortex of mice at six weeks of age, where blood levels of glucose appeared stable. 
Immunoblot showed the expected bands of GLUT1 at 45 and 55 kDa according to 
literature (Sivitz et al., 1989). Both bands were used for quantification, indicating no 
significant difference in GLUT1 abundance between SD and KD fed mice (Fig. 12D), 
confirming the results of the qRT-PCR analysis. 
Despite unaltered expression of GLUT1, metabolite levels within the brain still could be 
different due to changes in circulation. To test this hypothesis, metabolite profiling using 
gas chromatography/mass spectrometry (GC/MS) was performed in collaboration with 
Dr. Till Ischebeck from the department of Plant Biochemistry at the University of 
Göttingen. Metabolites were extracted from cortex of mice at six weeks of age and 
following metabolomics results will refer to this analysis. Interestingly, glucose within the 
cortex of KD fed animals decreased to around 30% of normal level when compared to 
SD fed mice (Fig. 12E), indicating decreased influx of glucose into the cortex. Metabolite 
levels were not corrected for residual blood content of cortical tissue. However, this 






Fig. 12: Global glycolytic changes upon KD feeding 
Expression analysis of Glut1 (A) and HK1 (B) at indicated time points in cortex of SD or KD fed 
mice are unaltered (n=4-5). Two-way ANOVA with Sidak’s post test. (C) Representative 
immunoblot for GLUT1 at six weeks of age in cortex of mice fed SD or KD and its quantification 
(D) reveal no alterations. Actin served as loading control (n=4-5; two sided Student’s t-test). (E) 
Glycolysis metabolites measured by GC/MS (all metabolites were measured in collaboration 
with Dr. Till Ischebeck) in cortex of mice at six weeks of age (n=6). Significance is indicated 
with *padj<0.05, **padj<0.005, ***padj<0.001 (Benjamini-Hochberg correction, DESeq2 R 
package) SD= standard diet; KD= ketogenic diet. 
 
therefore be of minor importance. Interestingly, all identified glycolytic intermediates 
remained unchanged.  This is in partial disagreement with previous results reporting 
increased glucose and glycolytic intermediates despite reduced blood glucose in rats fed 
a KD that was speculated to occur due to increased GLUT1 expression (DeVivo et al., 
1978; Roy et al., 2015). However, other studies found decreased brain glucose uptake 
in ketogenic rats (Jiang et al., 2011; Zhang et al., 2013). One could speculate that our 
finding is due to slowed glycolytic rate leading to accumulation of the intermediates or 
that the absolute glucose concentration is still high enough to support glycolysis at 
normal levels. Further experiments need to be performed to address these possibilities. 




expression of transporter and enzymes in cortex is unaltered and glucose is reduced 
within cortical tissue due to reduction of glucose concentration within the blood. 
 
2.7 ßOHB uptake is increased in cortex of mice on KD 
The brain responds to the KD by increasing the expression of MCT1, the major KB 
transporter (Leino et al., 2001; Noh et al., 2004). MCT1 expression determined by qRT-
PCR from cortex samples revealed no changes in Mct1 mRNA level up to five weeks of 
age in KD fed mice (Fig. 13A). At six weeks of age the expression of Mct1 almost 
doubled, suggesting adaptation to the KD. To test, whether MCT1 is also altered on 
protein level, immunoblot analysis of MCT1 at six weeks of age was performed (Fig. 
13B). Indeed MCT1 protein level was significantly increased in KD fed mice (Fig. 13C), 
suggesting increased transport of KB.  
 
Fig. 13: Transport of ßOHB across BBB is increased in KD fed mice 
(A) Expression of Mct1 is increased in cortex at 6 weeks of age by ketogenic diet (n=4-5). 
Asterisks depict significant differences with *p<0.05, **p<0.005, ***p<0.001, ****p<0.0001 (two-
way ANOVA with Sidak’s post test). (B-C) Immunoblot for MCT1 in cortex of mice fed SD or 
KD at 6 weeks of age shows increased protein abundance. Actin served as loading control 
(n=4). Asterisks depict significant differences with *p<0.05 (two-sided Student’s t-test). (D) 
Expression of Mct2 and Mct4 in cortex of SD or KD fed mice at 6 weeks of age is unaltered 
(n=4-5; Student’s t-test). (E) Fluorescent immunolabeling of MCT1 (green), S100b (red, 
astrocytic staining) and DAPI (blue, nuclear staining) in cortex of SD (left) and KD (right) fed 
animals at 6 weeks of age reveal strong increase of MCT1 mainly restricted to blood vessels. 
Scale, 10 µm. (F) ßOHB level as measured by GC/MS are increased in KD fed mice at 6 weeks 
of age (n=6). Significance is indicated with *padj<0.05, **padj<0.005, ***padj<0.001 






MCT2 and MCT4 are suggested to be mainly expressed on neurons and astrocytes, 
respectively (Bergersen et al., 2001; Pellerin et al., 1998). Regarding MCT2 expression 
it has been shown that this transporter does not react to the KD (Forero-Quintero et al., 
2017). In line, expression analysis of Mct2 and Mct4 at six weeks of age where MCT1 
was significantly increased, no expressional changes could be observed confirming the 
previous observations (Fig. 13D). To identify MCT1 expression on cellular level, double 
fluorescent immunolabeling of cortical sections of mice was performed. The majority of 
MCT1 signal was found on blood vessels in KD fed animals (Fig. 13E). Low signal 
intensity could be detected in mice fed the SD. Astrocytes stained with S100ß an 
astrocytic marker did not show visible co-labeling with MCT1 supporting that MCT1 is 
mainly expressed on endothelial cells (Gerhart et al., 1997). 
Whether the observed increase in MCT1 protein abundance could lead to increased 
ßOHB uptake, relative concentration of ßOHB was determined within cortex of mice at 
six weeks of age using GC/MS. Quantification revealed a 44-fold increase in ßOHB 
concentration in animals on KD (Fig. 13F), indicating functional uptake of ßOHB most 
probably via MCT1 into the brain. Of note, increased brain ßOHB levels upon KD feeding 
is in line with previous observations (DeVivo et al., 1978).  
Taken together, these results indicate that increased uptake of ßOHB is facilitated by 
MCT1 upregulation in response to feeding a KD. However, it just can be speculated how 
different brain cells take up KB since cell type specific MCTs were not responding to the 
KD and MCT1 signal was mainly found on endothelial cells.  
 
2.8 Influence of KD feeding on ketolytic enzymes in cortex 
Next, we asked whether ßOHB reaching the brain via MCT1 can be metabolized. To 
address this question, protein abundances of the ketolytic enzymes SCOT, BDH1 and 
ACAT1 in cortical samples were investigated using immunoblots. Fig. 1A shows 
representative immunoblots of cortex from six weeks old mice for all enzymes 
investigated. A stronger SCOT signal on the immunoblot was visible in samples of KD 
fed mice. In contrast, no obvious differences in protein expression could be observed for 
BDH1 and ACAT1. Quantification of protein levels of SCOT showed steady increase 
over time reaching statistical significance at five and six weeks of age in KD fed mice 
(Fig. 14B). In line with previous studies, this supports the notion that KD is able to induce 
upregulation of SCOT as it was previously shown in muscle of mice fed the KD (Schnyder 
et al., 2017). However, abundances of BDH1 and ACAT1 were unaltered at all 
investigated time points (Fig. 14C,D) despite minor increase at six weeks of age that 




tissue the rate-limiting enzyme SCOT increases likely to facilitate utilization of KB in KD 
fed mice. Based on the findings, that expression of MCT1 and SCOT was found to be 
highest at six weeks of age, further analyses were focused on this time point. 
 
 
Fig. 14: Ketogenic diet increases SCOT protein abundance in cortex of mice 
(A) Immunoblots of ketolytic enzymes SCOT, BDH1, ACAT1 and Actin (loading control) in 
cortex of mice fed SD or KD at six weeks of age. Quantification of protein abundance for SCOT 
(B), BDH1 (C) and ACAT1 (D) of mice on SD or KD reveals gradual increase of SCOT over 
time (n=4-5). Asterisks depict significant differences with *p<0.05, **p<0.005, ***p<0.001, 
****p<0.0001 (two-way ANOVA with Sidak’s post test). SD= standard diet; KD= ketogenic diet. 
 
2.9 Cell type specific isolation of cortical brain cells 
Our data indicate that the KD is able to increase MCT1 and SCOT expression within 
cortical tissue, probably due to increased ßOHB concentration in blood. To obtain cell 
type specific insights into changes induced by feeding a KD in mice, cell isolation from 
adult mouse cortices was performed. So far the most striking differences between SD 
and KD fed mice were found at six weeks of age which therefore served as time point 
for in depth analysis of isolated cell types. Cells were isolated using a refined protocol of 
the magnetic associated cell separation technique (MACS), based on tissue dissection, 
homogenization and labeling with magnetic antibodies enabling magnetic isolation of cell 
types (Fig. 15A). Proteomic analysis of cell fractions was performed. Astrocytes, 






Fig. 15: Isolation of different cell types from cortex of adult mice 
(A) Schematic representation of the Magnetic Associated Cell Sorting (MACS) based strategy 
to isolate different cell types from cortex of adult mice. O= Oligodendrocytes; A= Astrocytes; 
EC= Endothelial cells; N= Neurons. Proteome analysis of cell types reveal high purity and 
enrichment of specific marker proteins for astrocytes (B), oligodendrocytes (C), neurons (D) 
and endothelial cells (E) within the respective cell fraction. Graphs depict parts per million (ppm) 
of individual data points normalized to the mean ppm of the respective marker fraction (n=4). 
Protein mass spectrometry and statistical evaluation was performed in collaboration with Dr. 
Olaf Jahn and Lars Piepkorn. See appendix for full protein names. 
 
spectrometric analysis. To check for purity of isolated cell fractions, specific cell markers 
were extracted from the proteome dataset for every cell type. For astrocytes the cell 
marker ALDH1L1 (aldehyde dehydrogenase 1 family member l1), GLAST (glutamate 




2007; Cahoy et al., 2008; Shibata et al., 1997) (Fig. 15B). ALDH1L1 as well as GLAST 
show maximal enrichment in astrocytes with minimal variance between biological 
replicates. These markers were only low abundant in oligodendrocytes and endothelial 
cells and could not be detected in neurons. Despite higher variability within astrocytes, 
GYS1 could only be detected in this cell fraction. For oligodendrocytes the myelin 
proteins PLP1 (proteolipid protein 1), MBP (myelin basic protein) and CNP (2',3'-Cyclic 
Nucleotide 3' Phosphodiesterase) (Lappe-Siefke et al., 2003; Verity & Campagnoni, 
1988) were analyzed. All three markers exhibited their highest abundance in 
oligodendrocytes (Fig. 15B). Within other cell types, these markers could barely be 
detected. Neurons expressing the markers SYNPR (synaptoporin), SYNJ1 
(Synaptojanin 1) and CAPS1 (calcium-activator protein for secretion 1) (Farina et al., 
2015; Herrera et al., 2009; Jahn & Sudhof, 1994) (Fig. 15D) were investigated for 
accumulation within the neuronal fraction. All of these markers showed most abundance 
in neurons. In fractions of astrocytes, oligodendrocytes and endothelial cells these 
markers were not detected, indicating that these fractions are not contaminated with 
neurons. Endothelial cells were investigated for enrichment of the adhesion molecule 
ICAM2 (intercellular adhesion molecule 2), the endothelial PTPRB (receptor-type 
tyrosine-protein phosphatase beta) and MYOF (Myoferlin) needed for functional 
endocytosis within endothelial cells (Bernatchez et al., 2009; Fachinger et al., 1999; 
Renkonen et al., 1992). Expression of these markers appeared to be rather variable 
between biological replicates but clearly indicate enrichment of endothelial cells (Fig. 
15E). In addition, none of these markers was found in other cell fractions.  
Taken together these results show that our cell isolation protocol coupled to subsequent 
proteomic analysis yields highly enriched fractions of astrocytes, oligodendrocytes, 
neurons and endothelial cells. In addition, it underscores the purity of cell types by the 
nearly complete absence of markers not associated with the isolated fraction. This 
enables highly specific proteomic analysis of isolated cells from as less as just one single 
cortex.  
 
2.10 Proteomic analysis of isolated astrocytes from cortex of 
KD fed mice  
To investigate cellular adaptations to KD feeding in mice, astrocytes were analyzed using 
proteomics to address the question whether these cells alter their metabolism in 
response to feeding mice a KD. Astrocytes are ideally positioned to distribute metabolites 





1998; Pellerin & Magistretti, 1994). We speculated that astrocytes will change their 
metabolism to support neuronal function.  
By using proteomics, over 2100 different proteins could be detected in both dietary 
groups. As expected, from the volcano plot depicting expressional changes of proteins 
in relation to its significance, it is clearly visible that the proteomic composition of 
 
Fig. 16: Proteomic analysis of isolated astrocytes from cortex of KD fed mice 
(A) Volcano plot of astrocytes isolated from cortex of mice depicting differentially regulated 
proteins upon feeding a KD (n=4). (B) Pathway analysis (Top10) of the most differentially 
regulated proteins of astrocytes suggest upregulation of lipid metabolic pathways and 
downregulation of carbohydrate metabolism. X-axis depict percentage of proteins found to be 
differentially regulated within the proteome belonging to the respective pathway. Number within 




astrocytes from KD fed animals is strongly changed (Fig. 16A). To determine possible 
pathways that could be altered due to the KD, functional annotation analysis was 
performed using DAVID (Huang da et al., 2009a, 2009b) mainly focussing on distinct 
metabolic pathways of KEGG and GO_BP terms. The pathway analysis shows the 
Top10 ranking pathways with their respective p-values (Fig. 16B). Within astrocytes from 
KD fed mice there was a clear separation of proteins related to lipid or sugar metabolism 
as indicated by up and downregulated pathways. Metabolic pathways related to 
degradation of fatty acids and lipid synthesis were enriched in proteins with increased 
abundance, whereas sugar and carbohydrate metabolic pathways showed opposing 
changes. This finding indicates that astrocytes shift their carbohydrate-based 
metabolism to utilization of fatty acids. 
 
2.10.1 Astrocytes utilize KB upon feeding mice a KD 
Astrocytes derived from developing brain are thought to be able to utilize KB (Edmond 
et al., 1987). To address the question, whether astrocytes increase the necessary 
ketolytic enzymes when mice are fed a KD, proteins involved in ketolysis were 
investigated. Pathways were visualized using the software VANTED version 2.6.5 (Rohn 
et al., 2012) with log2 fold changes of individual mice depicted as heatmap (Fig. 17A). 
Astrocytes seem to import KB via MCT1 as indicated by significant higher abundance of 
this protein. In Addition, BSG (Basigin, also known as CD147) a glycoprotein necessary 
for the correct translocation of MCT1 to the plasma membrane (Kirk et al., 2000) was 
also increased to the same extent in astrocytes. MCT4 the proposed major astrocytic 
monocarboxylate transporter (Bergersen et al., 2001) was neither detected in the SD nor 
in the KD group. The ketolytic enzymes BDH1, SCOT and ACAT1 showed significant 
increase in protein expression in astrocytes with strongest increase in SCOT level 
suggesting increased rate of ketolysis of KB. Indeed, further evidence from 
immunohistochemistry of astrocytes point to enhanced utilization of KB. Astrocytes were 
visualized using ALDH1L1-EGFP mice, which express the green fluorescent protein 
(GFP) under the Aldh1l1 promotor ubiquitously expressed in astrocytes (Heintz, 2004) 
(Fig. 17B). Colabeling of SCOT clearly indicated increased abundance in sagittal 
sections of cortical slices in animals fed the KD. Due to mitochondrial localization, SCOT 
labeling appeared as punctual staining. Interestingly, although staining of SCOT within 
the astrocytic soma was visible, increased labeling was especially localized to astrocytic 
processes (arrowheads). Therefore, results obtained by proteomic analysis might 
underestimate the increase in SCOT protein expression, since processes might partially 





analysis of ketolytic enzymes and indicate that astrocytes readily utilize KB in cortex of 
KD fed mice.  
 
Fig. 17: Astrocytes readily utilize ketone bodies 
(A) Proteins identified by proteome analysis involved in transport and utilization of KB where 
mapped to the ketolysis pathway with corresponding Log2 fold changes of individual sample 
values (n=4). (B) Maximum intensity projection of sagittal brain sections of SCOT (red) labeling 
from animals receiving KD or SD. Astrocytes were visualized by using mice expressing EGFP 
(green) under the astrocytic promotor ALDH1L1. Arrowheads depict astrocytic processes and 
show increase in SCOT staining in mice on ketogenic diet. Scale, 5µm. SD= standard diet; KD= 
ketogenic diet. Significance is indicated with *q<0.05, **q<0.005, ***q<0.001, (moderated t-
statistics with multiple comparison correction). 
 
2.10.2 Glycolysis is decreased in cortical astrocytes of mice on KD 
As indicated by pathway analysis, sugar and carbohydrate based metabolic pathways 
were downregulated in astrocytes of mice fed a KD. Since glycolysis and pentose-
phosphate pathway (PPP) were identified with KEGG as well as in GO terms (see Fig. 
16B) these pathways were assessed in detail. All proteins identified by proteome 
analysis related to glycolysis and PPP were depicted (Fig. 18), regardless of significance 




proteins were strongly decreased indicating reduced glycolytic rate and PPP metabolism 
within astrocytes. Interestingly, despite obvious downregulation of glycolysis, GLUT1 
was slightly enhanced suggesting increased uptake of glucose. In addition, Hexokinase 
2 was increased as well. This might trap glucose within the cell as it is converted to G6P 
(Mergenthaler et al., 2013). However, the question arises what is the fate of G6P within 
astrocytes if all downstream glycolytic enzymes are decreased? One explanation could 
be that it is rather directed towards PPP than utilized via glycolysis. The PPP can be 
divided in a first oxidative and a following non-oxidative part. Glucose-6-phosphate 
dehydrogenase (isoforms G6PD2, G6PDX) is considered as the first and rate-limiting 
enzyme of this pathway (Stincone et al., 2015). 
 
Fig. 18: Astrocytes decrease glycolysis and PPP in mice on ketogenic diet 
Proteins identified by proteome analysis involved in glycolysis and pentose-phosphate pathway 
where mapped to their respective pathway with corresponding log2 fold changes of individual 
sample values (n=4), indicating pathway downregulation. Significance is indicated with 
*q<0.05, **q<0.005, ***q<0.001, (moderated t-statistics with multiple comparison correction; 





As the enzymatic step facilitated by G6PD is assumed to be unidirectional, the resulting 
product would unequivocally undergo utilization via this pathway. G6PDX was found to 
be slightly increased without reaching significance. However, G6PD2 was strongly 
increased in astrocytes of animals on KD (Fig. 18) suggesting that G6P is directed 
towards PPP metabolism. The oxidative part of PPP is necessary to produce reducing 
equivalents in form of NADPH and produces ribulose-5-phosphate necessary for RNA 
and DNA synthesis (Stincone et al., 2015) making it indispensable for normal cellular 
function. Interestingly, the second enzyme 6-phosphogluconolactonase (PGLS) of the 
oxidative PPP was downregulated (Fig. 18). However, PGLS is not necessarily needed 
since the formation of the product gluconate-6-phosphate can occur spontaneously and 
rapid (Miclet et al., 2001), thereby questions the necessity of an enzymatic facilitated 
step under conditions of reduced glucose availability. Enzymes related to the non-
oxidative part showed consistent downregulation indicating reduced flux probably due to 
reduced glycolytic intermediates (Fig. 18).  
Taken together, these data suggest that astrocytes in KD fed mice decrease glycolysis. 
However, the current results might also suggest direction of residual glucose into the 
PPP as GLUT1, HK2 and G6PD2 are upregulated that likely leads to trapping of glucose 
into the oxidative part of the PPP. In turn, this suggest that astrocytes spare glucose to 
produce reducing equivalents and precursors for nucleotide synthesis. To verify these 
findings experiments need to be performed to further shed light on this possibility. 
 
2.10.3 Astrocytes enhance ß-oxidation under ketogenic conditions  
Astrocytes are known to be the major cell type of the brain to be capable of metabolizing 
fatty acids via ß-oxidation (Edmond et al., 1987). Pathway analysis indicated 
upregulation of lipid and fatty acid related metabolism in astrocytes from animals fed the 
KD (compare Fig. 16B). To examine this possibility all identified proteins involved in ß-
oxidation were assessed. Indeed, most of the identified enzymes were significantly 
upregulated, although the rate-limiting protein CPT1 was unaltered in abundance (Fig. 
19A). These result suggest increased utilization of fatty acids within astrocytes of KD fed 
mice. However, further experiments need to be performed to see whether CPT1 enzyme 
activity is increased and thereby facilitates enhanced ß-oxidation. 
Astrocytes are also known to produce lipids that are critical for synapse formation (van 
Deijk et al., 2017). Lipid synthesis is mainly facilitated by the rate-limiting enzyme ACC 
(Awan & Saggerson, 1993) and the multifunctional enzyme fatty acid synthase (FASN) 




Investigation of lipid synthesis of astrocytes revealed conflicting result. Two isoforms of 
ACC exist (Phillips et al., 2010) that were found to be increased in astrocytes upon 
feeding mice a KD (Fig. 19B). In contrast, FASN was significantly decreased. Since 
FASN utilize malonyl-CoA produced by ACC1/2 this finding would indicate accumulation 
of this metabolite within astrocytes. This is of particular interest, since malonyl-CoA is a 
known inhibitor of ß-oxidation (McGarry & Brown, 1997). Malonyl-CoA can also be 
reconverted to acetyl-CoA via malonyl-CoA decarboxylase (MCD) (Dyck et al., 1998), 
but this enzyme could not be detected within astrocytes. To further address this issue, 
expression analysis via qRT-PCR in cortical tissue was performed and revealed an 
increase in Acc1 and Acc2 expression, the latter of them significantly, which supports 
proteomic data (Fig. 19C). In addition, Fasn was decreased, reflecting the reduction of 
protein abundance in astrocytes. Since findings obtained from cortical tissue seemed to 
 
Fig. 19: Astrocytes alter fatty acid metabolism when mice fed a ketogenic diet 
(A) Proteins identified by proteome analysis involved in ß-oxidation where mapped to their 
respective pathway with corresponding log2 fold changes of individual sample values (n=4) 
indicating increased utilization of fatty acids. (B) Abundance of Proteins involved in synthesis 
of fatty acids from astrocytes isolated from mice on SD or KD show inconsistent changes. Bars 
represent parts per million (ppm) normalized to mean value of SD condition with individual data 
points (n=4). Significance is indicated with *q<0.05, **q<0.005, ***q<0.001, (moderated t-
statistics with multiple comparison correction; “limma” Bioconductor package). (C) Expression 
analysis of genes involved in fatty acid synthesis from cortex of mice fed SD or KD reflect 
results of isolated astrocytes in regard of fatty acid synthesis (n=4-5). Asterisks depict 
significant differences with *p<0.05, (two sided Student’s t-test). SD= standard diet; KD= 





reflect changes within astrocytes, expression of Mcd was examined. Mcd was enhanced 
to the same extent as Acc1 and Acc2 (Fig. 19C). These findings suggest that astrocytes 
in KD fed animals increase the rate of malonyl-CoA synthesis and also indicates that ß-
oxidation in astrocytes is facilitated despite increased malonyl-CoA production by 
ACC1/2. 
 
2.11 Analysis of isolated oligodendrocytes from cortex of KD 
fed mice 
Oligodendrocytes are crucial for maintaining proper conduction velocity by insulating 
axons (Baumann & Pham-Dinh, 2001; Kettenmann & Ransom, 2005). In addition, it was 
shown that oligodendrocytes support axons metabolically by providing lactate 
(Funfschilling et al., 2012), indicating that oligodendrocytes support axons in a similar 
way to astrocytes (Pellerin & Magistretti, 1994). Therefore, it could be possible that upon 
feeding a KD in mice oligodendrocytes react in a similar manner as astrocytes. To test 
this hypothesis, isolated oligodendrocytes, derived from the same animals as astrocytes, 
were investigated by proteomic analysis. Almost 1800 proteins were detected in both 
dietary groups. Surprisingly, only minor differences between treatment groups could be 
detected (Fig. 20A), implying that oligodendrocytes seem to be mostly unchanged under 
ketotic conditions. Indeed, pathway analysis revealed only few upregulated pathways 
mostly related to ion and protein transport processes (Fig. 20B). No downregulated 
pathway passed the filter settings.  
Due to these little alterations we asked whether oligodendrocytes increase utilization of 
KB for energy production. Similar to astrocytes, oligodendrocytes seemed to enhance 
KB uptake by increasing MCT1 and BSG (Fig. 20C). Surprisingly this was not the case 
for ketolytic enzymes. Protein abundance of BDH1, SCOT and ACAT1 was not 
significantly increased in oligodendrocytes of KD fed animals, suggesting no increased 
ketolysis. Fluorescent co-labeling of oligodendrocytes stained for CNP revealed similar 
appearance in cortex of SD and KD fed mice (Fig. 20D). Although SCOT were obviously 
increased in tissue of ketogenic animals, SCOT labeling was obviously not increased in 
oligodendrocytes (arrowheads), further supporting that SCOT protein expression in 
oligodendrocytes might not be changed.  
Taken together these results imply that oligodendrocytes react differently to a KD 
compared to astrocytes. This is particularly important since oligodendrocytes were 
obtained from cortex of the same animals as astrocytes, enabling direct comparison of 
cell types within the same mouse. Furthermore, the findings suggest that 




suggest increased uptake. This raises the question of the fate of KB if they are taken up 









2.11.1 Oligodendrocytes might increase protein and ion transport 
Pathway analysis suggested that oligodendrocytes seem to enhance transport 
processes. Therefore, proteins involved in protein transport as well as vesicle-mediated 
transport were further assessed. Both pathways showed certain overlap of involved 
proteins so that both pathways were analyzed together. Indeed, all proteins showed 
consistent increase (Fig. 21A). Especially proteins of the Rab family were significantly 
increased. Rab proteins belong to the Ras superfamily of small GTPases and are thought 
to maintain membrane trafficking (Hutagalung & Novick, 2011; Stenmark & Olkkonen, 
2001). Rab proteins regulate release of exosomes (Blanc & Vidal, 2018) and 
oligodendrocytes have been shown to increase exosomal secretion upon treatment with 
the calcium-ionophore ionomycin in vitro (Kramer-Albers et al., 2007). Of note, Rab11b 
that is known to play a direct and significant role in exosome biogenesis (Blanc & Vidal, 
2018) was found to be increased. This might imply that oligodendrocytes increase 
exosomal secretion probably to support other cells. However, no conclusion can be 
drawn from these results regarding the possible cargo of the exosomes. Therefore, 
further experiments have to be conducted to address this and to confirm the current 
results.  
In addition to protein and vesicle-mediated transport, pathway analysis implicated 
enhanced ion transport within oligodendrocytes. A few proteins could be detected to be 
increased related to transport of ions (Fig. 21B). Oligodendrocytes are known to facilitate 
ion homeostasis (Kamasawa et al., 2005; Larson et al., 2018) that together with the 
current findings could suggest that oligodendrocytes might enhance ion buffering. 
Further experiments are needed to examine possible alterations of exosomal transfer 
and ion homeostasis in response to the KD in oligodendrocytes. 
Fig. 20: Proteome analysis of oligodendrocytes from cortex of mice fed KD 
(A) Volcano plot of oligodendrocytes isolated from cortex of mice depicting differentially 
regulated proteins upon feeding a KD (n=4). Note that only a small fraction of proteins exceed 
the significance threshold. (B) Pathway analysis of the most differentially regulated proteins 
reveal the top ranking up regulated pathways within oligodendrocytes with indicated p-values. 
No downregulated pathway passed the filter requirements. X-axis depict percentage of proteins 
found to be differentially regulated within the proteome belonging to the respective pathway. 
Number within Bars represent number of associated proteins. (C). Proteins identified by 
proteome analysis involved in transport and utilization of KB where mapped to the ketolysis 
pathway with corresponding log2 fold changes of individual sample values (n=4). Significance 
is indicated with *q<0.05, **q<0.005, ***q<0.001, (moderated t-statistics with multiple 
comparison correction; “limma” Bioconductor package). (D) Maximum intensity projection of 
sagittal brain sections from animals receiving KD or SD indicate no increase in SCOT signal 
(red) within oligodendrocytes (stained for CNP, green). Arrowheads depict SCOT signal within 






2.11.2 Transcriptomic analysis of isolated cortical oligodendrocytes 
To identify more subtle changes that might not be observed on protein level upon KD 
feeding in oligodendrocytes, these were again isolated and subjected to transcriptomic 
analysis. Transcriptomic analysis was performed in collaboration with Prof. Dr. Moritz 
Rossner and Nirmal Kannaiyan from the department of Psychiatry at the LMU Munich. 
In total nearly 14000 genes were identified with differentially regulated genes that 
reached the significance threshold (Fig. 22A). However, downregulated genes were not 
related to distinct metabolic pathways that were in the focus of this study (see Material 
and Methods) (Fig. 22). Interestingly, multiple pathways suggested to be enriched with 
upregulated genes associated to transport and ion transport processes reflecting results 
of the proteomic analysis (see Fig. 21A). This further strengthens the idea that 
oligodendrocytes might enhance transport processes and ion buffering in animals on KD. 
Hence, further analysis was focused on these pathways.  
 
Fig. 21: Oligodendrocytes might increase transfer processes under ketogenic 
conditions 
(A) Proteins involved in protein or vesicle mediated transport are significantly increased. (B) 
Ion transport might be increased in oligodendrocytes upon feeding a ketogenic diet. Log2 fold 
changes of individual samples normalized to the mean of SD condition are shown (n=4). 
Significance is indicated with *q<0.05, **q<0.005, ***q<0.001, (moderated t-statistics with 
multiple comparison correction; “limma” Bioconductor package). SD= standard diet; KD= 




2.11.3 Oligodendrocytes enhance ion transport processes in mice on KD 
DAVID functional annotation analysis revealed multiple pathways related to ion transport 
processes. Obviously all of these pathways share similar upregulated genes as can be 
seen from the Venn diagram (http://bioinformatics.psb.ugent.be/webtools/Venn/) (Fig. 
 
Fig. 22: Transcriptomic analysis of isolated oligodendrocytes of mice receiving KD 
(A) Volcano plot of oligodendrocytes isolated from cortex of mice depicting differentially 
regulated genes upon feeding a KD (n=4-5). (B) Pathway analysis (Top10) of the most 
differentially regulated genes of oligodendrocytes partially reflect enhanced proteomic 
pathways. X-axis depict percentage of genes found to be differentially regulated within the 






23A). Strongest overlap was identified between transport, ion transport and potassium 
ion transport. Involved proteins were therefore depicted together in Fig. 23B, revealing 
strong upregulation of these genes. However, no overlap between these genes and 
increased proteins of the proteomic analysis could be found (compare Fig. 21). 
Nevertheless, these results support the observations obtained from proteomic analysis 
since the transcriptomic investigation was independently performed leading to the same 
conclusion. The current data do not reveal the reason of increased ion transport in 
oligodendrocytes in response to KD feeding. However, these data together with 
proteomic results strengthen the hypothesis that KD feeding might enhance ion transport 
in oligodendrocytes.  
 
Fig. 23: Oligodendrocytes increase ion transport under ketogenic conditions 
(A) Venn diagram of the top-ranking transcriptomic transport pathways upregulated in 
oligodendrocytes when mice fed a KD reveal strong overlap of pathways. (B) Heatmap of all 
involved genes from pathways depicted in (A) show significantly increased expression 
indicating enhanced ion transport. Log2 fold changes of individual samples normalized to the 
mean of SD condition are shown (n=4-5). Significance is indicated with *padj<0.05, 
**padj<0.005, ***padj<0.001 (Benjamini-Hochberg correction, DESeq2 R package). See 
appendix for table of full protein names. 
 
2.12 Proteomic analysis of isolated endothelial cells  
Endothelial cells are known to regulate the flux of metabolites in and out of the brain 
(Abbott et al., 2010). It is therefore worth considering to what degree endothelial cells 




increased within endothelial cells by fluorescent immunohistochemistry (see Fig. 13E), it 
was speculated that endothelial cells could change from glucose metabolism to utilizing 
KB. Proteome analysis identified over 2200 different proteins in both dietary groups. 
Obviously, volcano plot of proteins of endothelial cells indicate that only a small portion 
of proteins changed in abundance upon KD feeding in mice (Fig. 24A). DAVID analysis 
revealed upregulated pathways related to cell cycle and proliferation, but with low 
 
Fig. 24: Proteome analysis of endothelial cells from cortex of mice fed KD 
(A) Volcano plot of endothelial cells isolated from cortex of mice depicting differentially 
regulated proteins upon feeding a KD (n=4). (B) Pathway analysis (Top10) of the most 
differentially regulated proteins of endothelial cells suggest that these cells downregulate most 
metabolic pathways when mice are fed a KD.  X-axis depict percentage of proteins found to be 
differentially regulated within the proteome belonging to the respective pathway. Number within 





number of proteins and p-values below the significance threshold (Fig. 24B). Surprisingly 
endothelial cells seemed to decrease multiple pathways related to metabolism as 
indicated by suggested downregulated pathways. Therefore, further analysis was 
focused on metabolic pathways. 
 
2.12.1 Endothelial cells do not increase KB utilization under ketosis 
Endothelial cells are the first cells that have access to KB in the circulation. It is therefore 
conceivable that they use them to generate energy. As expected MCT1 and BSG were 
significantly increased in endothelial cells (Fig. 25A) confirming histological results. On 
the other hand, BDH1 and SCOT showed a minor but non-significant decrease. 
 
Fig. 25:Endothelial cells do not increase ketolysis 
(A) Proteins identified by proteome analysis involved in transport and utilization of KB where 
mapped to the ketolysis pathway with corresponding Log2 fold changes of individual sample 
values (n=4). Significance is indicated with *q<0.05, **q<0.005, ***q<0.001 (moderated t-
statistics with multiple comparison correction; “limma” Bioconductor package). (B) Maximum 
intensity projection of sagittal brain sections from animals receiving KD or SD stained for 
isolectin (endothelial cells, green) and SCOT (red) indicated no increase in SCOT abundance. 
Arrowheads depict SCOT signal within endothelial cells. Scale, 2.5µm. SD= standard diet; KD= 




In contrast, ACAT1 was significantly decreased in endothelial cells from cortex of KD 
mice. Indeed, maximum intensity projections of labeled endothelial cells within the cortex 
of animals co-stained with SCOT indicated no visible difference of SCOT labeling 
(arrowheads) (Fig. 25B). This confirms observations of the proteome analysis. These 
findings imply that endothelial cells do not switch under ketosis to metabolizing KB. 
Furthermore, they suggest that endothelial cells only facilitate the transport of KB by 
increased expression of MCT1. However, it raises the question which metabolic source 
endothelial cells use for energy production. 
 
2.12.2 Endothelial cells may rely on glycolysis to provide energy 
Endothelial cells are assumed to be highly glycolytic cells (De Bock et al., 2013; Wong 
et al., 2017). Indeed, in vitro studies indicated that nearly all glucose is metabolized to 
lactate while only a minimal fraction is inserted into the TCA cycle (Eelen et al., 2018; 
Krutzfeldt et al., 1990). Increased ketolysis was not found in endothelial cells in the 
current study, indicating energy production via other metabolic pathways. To address 
the question whether endothelial cells change glycolysis in response to reduced glucose 
concentration of the blood, glycolytic enzymes were analyzed. No identified glycolytic 
enzyme were significantly changed in endothelial cells (Fig. 26A), suggesting that these 
cells use glucose for energy production also in case of reduced availability. However, as 
already indicated by pathway analysis almost all identified TCA cycle enzymes were 
significantly decreased (Fig. 26B). This supports the idea that endothelial cells generate 
almost their entire energy from glycolysis. Endothelial cells could therefore use glucose 
due to the direct and continuous supply by the blood stream even under KD induced 
blood glucose reduction. However, these results can not explain the diminished use of 
the TCA cycle within endothelial cells under ketosis taken into account that TCA cycle 
contributes already minimal to the metabolism under normal conditions. Therefore, 






Fig. 26: Endothelial cells rely on glycolysis to produce energy 
(A) Proteins identified by proteome analysis involved in glycolysis where mapped with 
corresponding Log2 fold changes of individual sample values, revealing no significant changes 
in glycolysis in response to KD feeding. (B) Proteins identified by proteome analysis involved 
in TCA cycle where mapped with corresponding Log2 fold changes of individual sample values, 
showing slight decreases (n=4). Significance is indicated with *q<0.05, **q<0.005, ***q<0.001 
(moderated t-statistics with multiple comparison correction; “limma” Bioconductor package). 
See appendix for table of full protein names.  
 
2.12.3 Fatty acid transport of endothelial cells under ketosis 
In astrocytes it was found that these cell type in addition to ketolysis might use fatty acids 
to produce energy via ß-oxidation (see Fig. 19A). This would indicate increased amounts 
of fatty acids available for its breakdown within astrocytes. Since endothelial cells 
regulate the entry of metabolites into the brain we speculated that upon KD feeding these 
cell type would increase fatty acid transport proteins. To address this possibility, we 




known transport proteins could be identified. FATP-1 and 4 the presumed major fatty 
acid transporter of the BBB (Hirsch et al., 1998; Mitchell et al., 2011) as well as 
FAT/CD36 needed for the transport of oleate (Mitchell et al., 2009) could not be detected. 
FABP5 the major fatty acid binding protein (Mitchell & Hatch, 2011) and FABP7 were 
identified but did not show changes due to KD feeding (Fig. 27A). In addition, ACSL1 
also assumed to import fatty acids (Doege & Stahl, 2006) was found to be unchanged. 
Surprisingly different plasma lipoproteins could be detected. Together with Albumin 
(ALB) that did not show changes in protein abundance, different apolipoproteins  could 
be identified, which are normally assumed as plasma located (Mahley et al., 1984). For 
APOA1 significant increase could be shown. Of note, APOA4 was also detected, 
although only in the ketogenic condition. Log2 fold changes could therefore not be 
displayed for this protein. This prompted us to analyze serum for changes of lipoproteins. 
Indeed, Coomassie stained SDS-gels revealed changes of different protein bands, later 
identified by MS analysis within blood serum of KD fed animals (Fig. 27B). From the 
Coomassie staining, albumin did not show changes within serum of KD fed animals 
reflecting results of the proteome analysis within endothelial cells. In contrast, APOA1,4 
and E did show obvious increased amounts within serum. It can be speculated that these 
lipoproteins were found within the proteome analysis of endothelial cells as residual 
amounts of blood serum and not to actual expression within these cells. However, these 
results indicate that transport of fatty acids is not actively increased in endothelial cells 
 
Fig. 27:Changes of fatty acid transport proteins in endothelial cells reflect serum 
changes induced by the ketogenic diet 
(A) Heatmap of proteins involved in fatty acid transport from isolated endothelial cells reveal no 
drastic increase upon feeding mice a KD. Log2 fold changes of individual samples normalized 
to the mean of SD condition are shown (n=4). Significance is indicated with *q<0.05, **q<0.005, 
***q<0.001 (moderated t-statistics with multiple comparison correction; “limma” Bioconductor 
package). (B) Coomassie staining of blood serum proteins from SD and KD fed mice, reveal 
obvious increase in fatty acid transport proteins, identified by mass spectrometry (n=3). SD= 





in mice fed the KD. Due to increased apolipoproteins in serum indicative of elevated fatty 
acid concentration, transport of lipids rather might be facilitated by passive diffusion. 
 
2.13 Proteomic analysis of cortical neurons  
Neurons are believed to be the cell type with the highest energy demand within the brain 
(Howarth et al., 2012) metabolizing the highest amount of glucose to meet their energetic 
needs. It is therefore of interest in which way neurons adapt to feeding mice a ketogenic 
diet where glucose availability is decreased. Due to reduced glucose 
 
Fig. 28: Proteome analysis of cortical neurons indicate enhanced oxidative metabolism 
induced by KD 
(A) Volcano plot of neurons isolated from cortex of mice depicting differentially regulated 
proteins upon feeding a KD, indicating massive changes (n=4). (B) Pathway analysis (Top10) 
of the most differentially regulated proteins of neurons with indicated p-values suggest strong 
increase in metabolic pathways. No downregulated pathway reached significance. X-axis 
depict percentage of enrichment of analyzed proteins. Number within Bars represent number 




availability and increased levels of ßOHB in cortex, we speculated that neurons will adapt 
similar to astrocytes by decreasing glycolysis and shift their metabolism towards KB 
utilization. Comparable to astrocytes, over 2100 proteins could be identified in both 
dietary conditions in neurons (Fig. 28A). Although three pathways were suggested to be 
downregulated within neurons (Fig. 28B) these did not reach statistical significance. With 
maximal enrichment, pathway analysis suggested enhanced oxidative phosphorylation 
within neurons. Surprisingly, glycolysis and carbohydrate-based pathways were 
detected to be increased in KEGG as well as in GO terms under ketogenic conditions. 
Therefore, this result was in direct contrast to the observed changes in astrocytes where 
glycolytic related pathways were exclusively diminished. 
 
2.13.1 Enhanced ketolysis in isolated neurons from cortex of KD fed mice 
In vitro experiments have shown that neurons are capable of ketolysis (Edmond et al., 
1987). We speculated that neurons will increase ketolysis in response to KD feeding in 
mice due to increased ßOHB availability. Similar to all other investigated cell types, 
neurons increased MCT1 and BSG protein abundance suggesting enhanced uptake of 
KB (Fig. 29A). Significant increase of ketolytic enzymes was found with highest log2 fold 
changes observed for SCOT. To support this finding, in sagittal brain sections neurons 
were co-labeled for SCOT and NeuN. NeuN is used as mature neuron marker and stains 
neuronal nuclei and perinuclear cytoplasm (Gusel'nikova & Korzhevskiy, 2015) enabling 
identification of neuronal cells (Fig. 29B). In addition, SCOT labeling was strongly 
enhanced in neurons of mice fed the KD. In contrast to astrocytes, SCOT labeling was 
mainly located within the cell soma (compare Fig. 17B). Taken together, these results 
indicate that neurons adapt in response to feeding mice a KD and increase KB uptake 
and utilization by increasing expression of necessary transporter and enzymes. 
Furthermore, by comparing the magnitude of enhancement especially of SCOT, neurons 






Fig. 29: Neurons react to feeding a KD by upregulation of ketolytic enzymes 
(A) Proteins identified by proteome analysis from cortical neurons involved in transport and 
utilization of KB where mapped to the ketolytic pathway indicating strong enhancement of this 
pathway. Log2 fold changes of individual sample values were depicted (n=4). Significance is 
indicated with *q<0.05, **q<0.005, ***q<0.001, (moderated t-statistics with multiple comparison 
correction; “limma” Bioconductor package). (B) Maximum intensity projection of sagittal brain 
sections from animals receiving KD or SD stained for SCOT (red). Neurons (NeuN) clearly 
accumulate SCOT signal under ketogenic conditions. Scale, 5µm. SD= standard diet; KD= 
ketogenic diet. 
 
2.13.2 Neurons increase glycolysis under ketogenic conditions 
Despite reduced glucose concentrations within the cortex of KD fed animals, pathway 
analysis within neurons suggested increased glycolytic rate. To examine this suggestion 
glycolytic proteins were further assessed. GLUT1 was not altered in neurons of ketogenic 
animals (Fig. 30). Interestingly, GLUT3 the major neuronal glucose transporter (Simpson 
et al., 2008) that was only detected within neurons showed marked increase indicating 
forced uptake of residual glucose into these cells. Except for two proteins (PGM1 and 
PGK2) all identified enzymes of glycolysis showed consistent increase suggesting 





Fig. 30: Neurons enhance glycolysis when mice are fed a ketogenic diet 
Proteins identified by proteome analysis from cortical neurons involved in glycolysis where 
mapped with corresponding Log2 fold changes of individual sample values (n=4), revealing 
extensive increases upon KD feeding in mice. Significance is indicated with *q<0.05, **q<0.005, 
***q<0.001, (moderated t-statistics with multiple comparison correction; “limma” Bioconductor 
package). See appendix for table of full protein names. 
 
metabolized to lactate instead to pyruvate since both identified isoforms of lactate 
dehydrogenase LDHA and LDHB showed increased expression. However, without 
further experiments this remains highly speculative. Taken together, these data suggest 
that neurons not only rely on glycolysis to produce energy under ketosis but even 
increase glycolytic rate. Considering that glucose availability is diminished under ketotic 







2.13.3 Mitochondrial respiration is enhanced in neurons of mice fed KD 
Ketolysis and glycolysis have been found in neurons of ketogenic animals to be 
increased. It therefore can be concluded that neurons may also increase mitochondrial 
respiration in response to this energy substrate maintaining pathways. To address this, 
TCA cycle proteins were analyzed to check if neurons also increase acetyl-CoA 
consumption. Indeed, most of the identified TCA cycle enzymes were increased in  
 
Fig. 31: Enhanced TCA cycle flux of neurons leads to increased TCA cycle intermediates 
in mice fed a KD 
(A) Proteins identified by proteome analysis from cortical neurons involved in TCA cycle where 
mapped with corresponding log2 fold changes of individual sample values (n=4), in addition to 
identified TCA cycle intermediates identified from total cortex of mice using GC/MS (±SEM, 
n=6). Increase in TCA cycle proteins correlate with enhanced TCA cycle metabolites. Values 
of SD condition were set to 1. (B) Enhanced levels of adenosine in cortex of KD mice might 
indirectly reflect enhanced neuronal TCA cycle. Significance is indicated with *q<0.05, 
**q<0.005, ***q<0.001, (moderated t-statistics with multiple comparison correction; “limma” 
Bioconductor package) for proteins and with *padj<0.05, **padj<0.005, ***padj<0.001 
(Benjamini-Hochberg correction, DESeq2 R package) for metabolites. SD= standard diet; KD= 
ketogenic diet. See appendix for full protein names. 
 
cortical neurons of KD fed mice (Fig. 31A). Additionally, TCA cycle metabolites identified 
by metabolite profiling from cortex tissue of mice were mapped to the respective position 
within the pathway. Values of SD fed mice were set to 1 and graphs represent fold 
changes of identified intermediates. All identified metabolites were increased upon 
feeding mice a KD and were therefore in line with enhanced TCA cycle found within 
neurons. This finding suggest that increased concentration of TCA cycle metabolites 
found within cortex of KD fed mice is attributable to increased metabolism of acetyl-CoA 





Fig. 32: Ketogenic diet enhances mitochondrial respiration in isolated neurons 
Proteins identified by proteome analysis from cortical neurons associated to oxidative 
phosphorylation where mapped with corresponding Log2 fold changes of individual sample 
values (n=4), revealing enhancing effects on mitochondrial respiration of ketogenic diet feeding 
in mice. Numbers below complexes denote significant/identified/overall associated proteins. 
Significance is indicated with *q<0.05, **q<0.005, ***q<0.001, (moderated t-statistics with 
multiple comparison correction; “limma” Bioconductor package). See appendix for full protein 
names. 
 
has been speculated that the KD is able to increase the adenosine pool by increased 
production of ATP (DeVivo et al., 1978; Kim et al., 2010; Maalouf et al., 2009). The finding 
that adenosine was found to be increased nearly 5-fold in cortex of KD fed mice further 
support enhanced TCA cycle in cortical tissue of KD fed mice (Fig. 31B). As indicated 
from the pathway analysis, neurons are likely to enhance oxidative phosphorylation. To 
address this opportunity and further collect evidence that would support enhanced 
mitochondrial respiration in neurons under ketotic conditions, proteins involved in 
oxidative phosphorylation were examined. The numbers below each respiratory complex 





complex (Fig. 32). Each identified protein is depicted below to assess the individual log2 
fold change. Indeed over 74% of all identified proteins involved in oxidative 
phosphorylation were significantly increased in neurons when mice are fed a KD. Given 
that the proteomic analysis covered approximately 58% of all proteins involved in 
oxidative phosphorylation this strongly suggest enhanced mitochondrial respiration 
within neurons. Taken into account that also TCA cycle enzymes in neurons and TCA 
cycle metabolites in cortex were increased, this finding supports the idea of enhanced 
energy production within neurons in ketogenic animals. However, these data do not 
explain to what reason neurons do enhance their metabolic rate under ketogenic 
conditions. 
 
2.13.4 Synaptic transmission is enhanced in neurons of ketogenic animals 
The current results indicated enhanced metabolism in cortical neurons of mice fed a KD. 
It has been calculated that the biggest portion (44%) of the total energy expenditure 
within cortical neurons is attributable to synaptic transmission (Howarth et al., 2012). It 
is conceivable that increased energy production in neurons would indicate enhanced 
synaptic transmission. To test this possibility proteins identified by proteome analysis 
within neurons involved in synaptic transmission were assessed to receive an impression 
of possible changes. 32 proteins could be identified in both dietary groups to be involved 
in synaptic transmission according to KEGG data sets (Fig. 33A). Among these, known 
representatives of synaptic vesicle loading and release like vesicular glutamate 
transporter 1 (VGLUT1), synaptotagmin 1 (SYT1) and vesicle-associated membrane 
protein 2 (VAMP2) (Park & Ryu, 2018; Schoch et al., 2001; Wojcik et al., 2004) were 
found. Additionally, multiple subunits of the vacuolar H+-ATPase that are important for 
refilling of newly formed synaptic vesicles (Hnasko & Edwards, 2012) were identified 
together with additional components of the synaptic vesicle cycle. As speculated, most 
of the identified proteins showed marked increase in neurons of KD fed mice, suggesting 
enhanced neurotransmission within the cortex of ketogenic animals. However, 
considering that the isolated neuronal fraction is comprised of different neuronal subsets 
conclusions regarding the type of neurotransmission i.e. inhibitory or excitatory are not 
possible. Furthermore, evidence that feeding a KD does alter neurotransmission comes 
from metabolite profiling analysis of cortical tissue identifying the major excitatory and 
inhibitory neurotransmitter glutamate and GABA, respectively (Fig. 33B). Interestingly, 
glutamate was found to be decreased by 50%, whereas GABA concentration within the 
cortex was just slightly diminished. Glutamine the precursor of both neurotransmitters 
was unaltered. This finding might suggest that neurotransmitter balance is indeed altered 





Fig. 33: KD fed mice might increase synaptic transmission in neurons inducing global 
changes of neurotransmitters 
(A) Proteins associated with synaptic transmission are consistently upregulated, indicating 
enhanced neuronal activity. Depicted are log2 fold changes of individual sample values (n=4). 
Significance is indicated with *q<0.05, **q<0.005, ***q<0.001, (moderated t-statistics with 
multiple comparison correction; “limma” Bioconductor package). (B) Neurotransmitter level 
measured by GC/MS in cortex of SD and KD fed mice. Bars represent mean fold change 
normalized to SD fed mice with individual data points (n=6). Significance is indicated with 
*padj<0.05, **padj<0.005, ***padj<0.001 (Benjamini-Hochberg correction, DESeq2 R 
package). SD= standard diet; KD= ketogenic diet. See appendix for full protein names. 
 
glutamate is due to metabolic changes of the KD or because of enhanced synaptic 
transmission in neurons. Taken together, these findings strongly suggest that neurons 
increase synaptic transmission in response to feeding a KD in mice, which might lead to 
altered neurotransmitter concentrations. Precisely defined experiments need to be 
performed to address the question what kind of neurotransmission is enhanced in 






2.13.5 KD feeding in mice increases motor activity 
To address the question whether altered neurotransmission could cause functional 
consequences an open field test was performed, that commonly measures the 
exploratory behavior and general activity of rodents (Gould et al., 2009). Fig. 34A shows 
a schematic representation of the open field and representative tracking of travel 
distance from SD and KD fed mice at six weeks of age. The data showed that mice fed 
the KD significantly increased travel distance indicative of enhanced motor activity (Fig. 
34B). The open field is also a measurement of anxiety behavior as parameters like 
number of visits within the center or duration within the center can be assessed (Gould 
et al., 2009). Decreased number of visits or duration within the center would indicate 
increased anxiety in mice. However, visits within the center (Fig. 34C) and time spent in 
center (Fig. 34D) were unaltered in mice fed a KD in comparison to mice on SD. This 
indicates that KD does not lead to altered anxiety behavior. Taken together, these 
findings suggest physiological changes upon feeding mice a KD probably due to changes 
in neurotransmission within cortical neurons without affecting anxiety behavior.  
 
Fig. 34: Ketogenic diet enhances motor activity in mice 
(A) Representative traces of travel distance from mice on SD and KD, respectively at 6 weeks 
of age during an Open field test to assess behavioral changes upon feeding a KD. (B) Mice on 
KD were significantly more active than SD fed mice, indicated by total travel distance. KD fed 
mice exhibited no signs for anxiety revealed by unchanged center visits (C) and duration within 
the center area (D). Asterisks depict significant differences with *p<0.05, **p<0.005, 








3.1 KD prevents metabolic switch upon weaning but does not 
influence brain development 
Ketone bodies serve as important energy source for the brain during suckling but are 
quickly replaced by glucose after start of carbohydrate ingestion during weaning (Nehlig, 
1999, 2004). In this study we asked the following questions: (1) Is it possible to increase 
ketolytic enzymes and KB transport by feeding a KD thereby reflecting the suckling 
period? (2) In which regard do brain cells change their metabolism in response to KD 
feeding? (3) Will they switch to ketolysis and reduce glucose utilization and (4) what are 
the consequence for overall brain metabolism? 
 
Weaning mice on a KD resulted in reduced blood glucose and increased ßOHB 
concentration in accordance with previous results (Hernandez et al., 2018; Selfridge et 
al., 2015). Subsequently, KB transporter and ketolytic enzymes within the brain 
increased over time in KD fed animals when compared to normally fed animals. 
Transporter expression (e.g. MCT1) and activity of ketolytic enzymes decline after 
weaning in rodents fed carbohydrate rich chow (Krebs et al., 1971; Leino et al., 1999; 
Page et al., 1971). Hence, our results suggest that weaning mice on a KD is able to 
prevent the metabolic switch and maintain high expression of MCT1 and necessary 
enzymes such as SCOT for KB utilization. This is probably induced by increased 
concentration of ßOHB found in cortex tissue while glucose concentration is decreased 
forcing the brain to utilize KB instead of glucose. Therefore, we speculate that the 
metabolic switch seen upon weaning is dependent on dietary changes and not induced 
by a brain cell intrinsic program.  
 
Mice fed a KD exhibited reduced body growth compared to mice on SD. Indeed, feeding 
a KD has been implicated with reduction in body weight in adult mice (Kennedy et al., 
2007; Selfridge et al., 2015) and reduced growth in children (Vining et al., 2002). We 
therefore investigated whether KD feeding would lead to altered brain growth and 
development. Body growth during the juvenile period is assumed to be dependent on 
insulin and insulin like growth factor 1 (IGF1) (Bergqvist, 2012) and IGF1 was found to 
be decreased in children adhering to the KD for 12 month (Spulber et al., 2009) 
explaining the reduced growth rate. Insulin level in mice were found to be decreased 
when fed a KD as consequence of low carbohydrate consumption, suggesting that the 
slowed body growth observed in KD fed mice is attributable to altered insulin level and 





age were unaltered despite reduced body weight at that time. One explanation could be 
that brain volume is already stable after three weeks of age (Hammelrath et al., 2016) 
when body weight of KD and SD fed mice did not differ in the current study. It is also 
conceivable that brain growth is not dependent on insulin signaling since no alterations 
in Akt, GSK3ß and mTOR phosphorylation mediated by insulin could be found in mice 
fed the KD despite differences in peripheral insulin sensitivity (Selfridge et al., 2015).  
 
KB are thought to be the preferred substrate for synthesis of lipids and sterols during 
development needed for myelination (Bergstrom et al., 1984; Edmond, 1974; Webber & 
Edmond, 1979). However, it appeared that myelination within the cortex was unaltered 
in KD fed mice at six weeks of age compared to SD fed mice indicating no influence of 
the KD on the speed of myelination. One could therefore assume that the developmental 
program of myelination in contrast to brain metabolism is controlled endogenously and 
not dependent on dietary supplementation. However, it has to be taken into account that 
only the latest time point at six weeks was investigated where effects already could have 
been compensated. The KD could support myelination during suckling and shortly before 
weaning when rate of myelination is highest (Norton & Poduslo, 1973). We did not 
observe differences in myelination in optic nerve at three weeks of age indicating that 
the KD does not influence rate of myelin formation during the peak of myelination. We 
speculate that the duration of KD feeding from P17 to P21 is not sufficient to induce 
alterations in myelin synthesis. Additionally, one has to consider that myelination in SD 
fed mice is already sufficient to maintain nerve conduction and insulation. It could be 
worth considering to test influence of KD feeding under developmental demyelination to 
assess possible effects of the KD under disease conditions. At two month of age nearly 
all axons are myelinated within the optic nerve, while myelination is still ongoing in the 
corpus callosum at least until four month of age (Biffiger et al., 2000; Remahl & 
Hildebrand, 1982; Yates & Juraska, 2007). Our investigation was based on optic nerve 
and cortex tissue and does not necessarily reflect the state of myelination within the 
corpus callosum where KD feeding could have other impacts.  
 
Investigation of cognitive abilities by assessing memory and learning ability in KD fed 
mice further supported results from morphological analysis that weaning mice on a KD 
does not impair brain development. However, evidence from other studies report 
conflicting results regarding cognitive performance influenced by a KD. One study 
reported cognitive deficits in weanling rats fed a KD (Scichilone et al., 2016), while 
another study reported significant improvements of cognition in young and aged rats 




al., 2018). Therefore, conclusions drawn from our experiments regarding cognitive 
effects of the KD has to be considered carefully. Taken together, our data suggest that 
weaning mice on a KD prolongs ketosis into adulthood, thereby increasing expression of 
ketolytic enzymes and KB transporter. Additionally, in the current study KD did not 
influence brain growth, myelination or cognition in mice. 
 
3.2 Efficient isolation of cell types from mouse cortex 
The KD has been investigated extensively over the last decades in vitro and in vivo. Cell 
culture experiments gained insights on the KD’s action but lacking the contribution of 
peripheral metabolism and influence of the BBB. In contrast, in vivo studies in the past 
could not resolve cell type specific changes in response to the KD although enable 
investigation under physiological conditions. 
To overcome these obstacles, cell isolation from adult mouse brain was applied to 
investigate in vivo influence of the KD with cell type specific resolution. Therefore, we 
optimized the MACS technique that enabled region and cell type specific analysis from 
individual animals. Most studies using MACS technology were conducted using multiple 
whole brains to isolate sufficient number of cells (Batiuk et al., 2017; Berl et al., 2017; 
Sharma et al., 2015), thereby losing region specificity and differences between individual 
animals cannot be attributed. Here we showed that cell isolation of certain cell types is 
possible from as little as one single cortex enabling region specific investigation of cells 
in addition to analysis of biological variability. Furthermore, we were able to isolate 
multiple cell fractions from the same cortex enabling comparison of cell types from the 
same tissue, individual and brain region. Also other studies have demonstrated isolation 
of multiple cell fractions, however using whole brains or multiple animals (Merienne et 
al., 2019; Swartzlander et al., 2018). So far, only one study reported was able to isolate 
different cell types from single animals and comparable amounts of tissue as performed 
in our study (Holt & Olsen, 2016). Subsequent proteomic or transcriptomic approaches 
that were used in our study enabled highly specific analysis of cell types in a region-
specific manner. Furthermore, comparison of different cell fractions from the same region 
and animal is in principal possible. In conclusion, the optimized MACS technique 
developed in this study coupled to –omic analyses is a powerful method to analyze cell 






3.3 Endothelial cells provide substrates for the brain under 
ketosis but rely on glycolysis for energy production  
Brain endothelial cells controls the entry of metabolites and molecules into brain 
parenchyma and protect the CNS from neurotoxic substances by formation of the BBB 
(Abbott et al., 2010). However, little is known about endothelial cell metabolism and 
results obtained originate mostly from in vitro studies that do not fully reflect the in vivo 
situation (Eelen et al., 2018). Proteomic analysis revealed increased expression of MCT1 
in endothelial cells that we also observed in histological staining’s suggesting that 
endothelial cells react to increased concentrations of KB within the circulation induced 
by the KD (Fig. 35). Interestingly, endothelial cells do not seem to increase ketolysis. 
This indicates that KB are rather shuttled to brain cells (e.g. astrocytes) than used for 
energy production although KB can be utilized by brain capillaries in vitro (Homayoun & 
Bourre, 1987). Indeed, endothelial cells are highly glycolytic and produce approximately 
85% of their total ATP from glycolysis (De Bock et al., 2013) and might therefore shuttle 
KB to other cells. That might explain the finding of unaltered glycolysis in endothelial 
cells under ketosis. We speculate that endothelial cells rely on glycolysis even under 
reduced glucose concentrations within the blood (Fig. 35). Since endothelial cells are 
constantly supplied with glucose by the circulatory system, reduced blood glucose might 
not affect glycolysis within endothelial cells.  
 
TCA cycle enzymes were found to be decreased in endothelial cells that might implicate 
reduced mitochondrial respiration under ketosis. Since glucose is nearly completely 
metabolized to lactate by glycolysis in endothelial cells mitochondrial respiration might 
be fueled by other substrates like fatty acids or glutamine (Spolarics et al., 1991). Indeed, 
glucose deprivation in vitro causes increased flux of fatty acid oxidation into endothelial 
cells (Dagher et al., 2001). Under ketosis, increased level of fatty acids could favor ß-
oxidation in endothelial cells to prevent energy depletion as consequence of reduced 
glucose concentrations. However, our current data do not indicate altered ß-oxidation in 
endothelial cells in response to KD. More recent studies indicate that fatty acid oxidation 
in proliferative endothelial cells is not used for energy production (Kalucka et al., 2018; 
Schoors et al., 2015) but supports nucleotide synthesis (Schoors et al., 2015). In 
contrast, quiescent endothelial cells reduce TCA cycle flux despite increased fatty acid 
oxidation (Kalucka et al., 2018). Therefore, the presented data suggest that endothelial 
cells under ketogenic conditions are likely to resemble a quiescent state due to reduction 




The concentration of fatty acids in serum is increased upon ingestion of a KD (Cunnane 
et al., 2002; Fraser et al., 2003) (Fig. 35). The finding that astrocytes increase ß-oxidation 
in mice fed the KD propose enhanced availability of fatty acids within the brain. Hence, 
fatty acids must cross the BBB. However, increased abundance of lipid transport proteins 
could not be detected in endothelial cells. In addition to active transport fatty acid can 
cross the BBB by passive diffusion (Doege & Stahl, 2006; James A. Hamilton & Brunaldi, 
2007). In line, the KD raised brain levels of docosahexaenoic and arachidonic acid (Taha 
et al., 2005), two fatty acids that are transported by passive diffusion (Ouellet et al., 
2009). We speculate that transport of fatty acids is mainly facilitated by passive diffusion 
driven by increased amounts of free fatty acids within the circulation in mice on the KD.  
 
3.4 Astrocytes spare glucose for neurons and use KB and fatty 
acids for energy production 
Under normal glucose availability it has been proposed that astrocytes supply neurons 
metabolically by shuttling lactate (Pellerin & Magistretti, 1994), but it is unknown what 
substrates could be provided to neurons under ketosis. The present data suggest that 
astrocytes reduce glycolysis, in agreement with in vitro and ex vivo experiments of a 
previous study using fasted mice (Valdebenito et al., 2016). However, GLUT1 
abundance was slightly increased suggesting that uptake or transport of glucose in 
astrocytes is not decreased. This predicts that residual glucose might be shuttled to other 
cells to increase its availability e.g. for neurons under low glucose conditions (Fig. 35). 
 
Given that astrocytes reduce glucose metabolism under ketotic conditions they require 
an alternative source to meet their energy demands. Astrocytes are able to utilize KB 
(Edmond et al., 1987) and the KD enhanced ßOHB concentration in cortex of KD fed 
animals. We therefore speculated that astrocytes would switch to KB utilization to 
produce energy. Indeed, increased abundance of ketolytic enzymes concomitant with 
increased MCT1 expression in astrocytes was observed supporting our hypothesis. 
Surprisingly, in addition to enhanced ketolysis we observed increased ß-oxidation in 
astrocytes, which has not been reported so far. However, it appears likely that astrocytes 
also increase fatty acid oxidation taken into account that astrocytes are probably the best 
equipped cell type for ß-oxidation in the brain (Edmond et al., 1987; Romano et al., 2017). 
Furthermore, the KD increases fatty acid availability within the brain (Taha et al., 2005), 
enabling astrocytes to maintain the increased rate of ß-oxidation for energy production. 
Astrocytes might accumulate malonyl-CoA a potent inhibitor of ß-oxidation (McGarry & 





this contradictory finding we speculate that astrocytes still increase ß-oxidation and 
prevent its inhibition by reconversion of malonyl-CoA to acetyl-CoA by MCD as indicated 
by increased mRNA expression of Mcd in cortex.  
In conclusion, our data suggest that astrocytes shift their metabolism from using glucose 
towards ketolysis and ß-oxidation thereby utilizing KB and fatty acids. This supports the 
idea that glucose could be shuttled to neurons as substrate for energy production. In 
addition, since astrocytes seem not fully relying on ketolysis it might be that KB are 
partially shuttled to other cells (Fig. 35). 
 
3.5 Oligodendrocytes do not exhibit metabolic changes but 
might enhance ion buffering in response to KD feeding in mice 
Considering the hypothesis that astrocytes and oligodendrocytes shuttle lactate to 
supply neuronal metabolism (Funfschilling et al., 2012; Pellerin & Magistretti, 1994) we 
hypothesized that oligodendrocytes would react similar to astrocytes. Surprisingly, 
oligodendrocytes did not show increased usage of KB under ketogenic conditions. This 
was suggested by unaltered abundance of ketolytic enzymes while at the same time 
import by MCT1 was increased. Indeed, SCOT activity in oligodendrocytes was found to 
be over 50% lower compared to astrocytes (Chechik et al., 1987; Edmond et al., 1987; 
Poduslo, 1989), indicating that oligodendrocytes are not prepared to use KB to the same 
extent as astrocytes and instead rather pass it on to other cells (e.g. neurons) by MCT1 
mediated transport (Fig. 35). Interestingly, although oligodendrocytes utilize glucose in 
comparable amounts to astrocytes they release less lactate (Amaral et al., 2016). This 
suggests enhanced insertion of pyruvate into TCA cycle thereby increasing efficiency of 
ATP production from glucose. We therefore speculate that oligodendrocytes are able to 
meet their metabolic needs by efficient utilization of glucose and are not dependent on 
additional usage of KB.  
 
Proteomic analysis revealed increased abundance of proteins associated with ion 
buffering in oligodendrocytes, which was later independently supported by transcriptome 
analysis. It is known that oligodendrocytes are critically involved in ion homeostasis and 
potassium buffering through expression of connexins and K+ channels (Kamasawa et 
al., 2005; Larson et al., 2018; Menichella et al., 2006). Significant changes in connexin 
expression in oligodendrocytes could not be detected but transcriptomic data revealed 
changes in expression of K+ channel genes (e.g. Kcnb1, Kcnma1, Kcnq2, Kcne2, Kncj13, 
Kcnt1). Although the major K+ channel Kir4.1 known to control potassium accumulation 




our data indicated enhanced need for potassium clearance in brain of ketogenic diet fed 
mice. Potassium buffering is especially important during neuronal activity to prevent 
seizures (Larson et al., 2018; Menichella et al., 2006). Considering that enhanced 
synaptic transmission was found in neurons leading to enhanced potassium release 
during signal transduction, enhanced oligodendrocytic potassium buffering becomes 
reasonable.  
 
3.6 KD feeding in mice raise neuronal metabolism and 
increases synaptic transmission 
Neurons like astrocytes are able to take up and catabolize KB for energy production 
(Chechik et al., 1987; Edmond et al., 1987; Maurer et al., 2011). We speculated that 
neurons in similarity to astrocytes change their metabolism and increase ketolysis, 
thereby reducing the rate of glycolysis. Indeed, ketolytic enzymes were significantly and 
consistently increased suggesting that neurons use KB to fuel mitochondrial respiration 
for energy production (Fig. 35). 
Glucose concentration within the cortex was found to be reduced probably as 
consequence of decreased glucose blood levels. However, increased levels of glucose 
in cortex and plasma have been previously reported (Melo et al., 2006). The authors 
speculated that increased cerebral glucose concentration could reflect reduced 
glycolysis. At least in principle increased oxidative metabolism fueled by KB should 
downregulate glycolysis either by modulation of phosphofructokinase I, or by inhibition 
of pyruvate dehydrogenase (Ma et al., 2007; Melo et al., 2006). Indeed, in rat 
hippocampal slices acetyl-CoA production from glucose was significantly attenuated 
after adding ßOHB. This indicates that KB are capable of inhibiting glycolytic flux 
(Valente-Silva et al., 2015). In contrast to our expectations we found a strong and 
consistent increase in the abundance of glycolytic enzymes in neurons. From this we 
conclude that KD enhances the utilization of glucose in neurons. Our finding that neurons 
increased the expression of GLUT3 indicating enhanced glucose uptake further supports 
this observation. GLUT3 is of particular interest due to its higher affinity and transport 
rate compared to GLUT1 (Simpson et al., 2008). Thereby neurons may be able to take 
up sufficient amount of glucose even under low glucose conditions to secure glycolysis 
(Fig. 35). Taking into account that glucose consumption linearly correlates with HK1 
mRNA expression and immunofluorescence (Lundgaard et al., 2015) and that this 
enzyme exhibited the highest log2 fold changes further supports our hypothesis of 
enhanced neuronal glucose utilization. However, from the current data the fate of 





isoforms indicated enhanced formation of lactate. This assumption is in agreement with 
the aforementioned finding that KB inhibit acetyl-CoA formation from glucose since 
lactate formation was not affected (Valente-Silva et al., 2015). Melo and colleagues 
(2006) found increased glucose concentration in cortex of KD fed rats and speculated 
that this would indicate reduced glycolysis. If this holds true our data would imply normal 
glycolytic rate in cortex of KD due to the finding that glucose concentration in cortical 
tissue was comparably decreased to blood. We speculate that cortical glycolytic rate is 
unaltered in KD fed mice due to enhanced glycolysis in neurons, thereby compensating 
the reduced glycolytic rate observed in astrocytes. 
KB can account for 60-70% of energy production within the brain whereas the remaining 
30-40% need to be generated by glucose metabolism (Cahill, 2006; Grabacka et al., 
2016; Owen, 2005). In line, in neurons 38% of neuronal substrate oxidation had to be 
provided by glucose in fasted rats infused with ßOHB (Chowdhury et al., 2014). This is 
probably due to the fact that synaptic vesicle loading requires high local ATP 
concentrations provided by glycolytic enzymes within synapses than high overall ATP 
level generated in the soma (Fedorovich & Waseem, 2018). Taking into account that 
lactate supply from astrocytes might be diminished due to reduced glycolysis, we 
speculate that neurons enhance glycolysis to maintain their overall energy metabolism. 
In contrast to glucose, KB utilization inevitably produce acetyl-CoA thereby increasing its 
concentration (Yudkoff et al., 2005). As consequence, acetyl-CoA needs to be 
catabolized via the TCA cycle (Cotter et al., 2013; Yudkoff et al., 2005). Enhanced TCA 
cycle activity was found in neurons with concomitant increase in TCA cycle intermediates 
within the cortex. We hypothesize that acetyl-CoA derived from KB forces neurons to 
increase TCA cycle and subsequently oxidative phosphorylation to prevent its 
accumulation. As a result, ATP level could be elevated. Indeed, others have reported 
elevated ATP concentration under ketogenic conditions (DeVivo et al., 1978; Kim et al., 
2010). Elevated adenosine levels have been assumed already earlier due to increased 
ATP levels in response to KD feeding (Maalouf et al., 2009). Our observation of elevated 
adenosine ratio in ketogenic animals now directly supports this assumption. Therefore, 
our findings are in agreement with previous studies indicating that KD feeding increases 
energy levels. We can further speculate that this occurs due to enhanced mitochondrial 
respiration observed in neurons.  
 
However, these findings raise the question after the use of the additional ATP content 
within the brain under ketogenic conditions. Under disease conditions it has been 
assumed that the improved mitochondrial respiration and energy production leads to 




multiple mechanisms (Gano et al., 2014; Koppel & Swerdlow, 2018; Maalouf et al., 2009; 
Masino & Rho, 2018). So far, the function of increased ATP availability under 
physiological conditions has never been addressed. Based on the current findings, we 
speculate that enhanced neuronal metabolism could lead to increased synaptic 
transmission. The finding that KD fed mice exhibited decreased neurotransmitter levels 
could further indicate altered neuronal activity. However, different neuronal cell types 
could not be discriminated that would allow conclusions of the type of altered neuronal 
signaling.  
In this study we based our investigation on cortical tissue including the motor cortex. 
Therefore, increased synaptic transmission could result in enhanced motor activity. To 
test this assumption, motor activity was recorded in mice fed the KD. In fact, mice fed 
the KD showed significantly elevated motor activity that could point to enhanced synaptic 
transmission. Rats fed the KD exhibited similarly enhanced motor performance (Ziegler 
et al., 2005) and neural activation increases in Engrailed 2 null mice when pre exposed 
to the KD during the juvenile period (Verpeut et al., 2016). Taken together, the current 
data imply that the KD is able to enhance neuronal metabolism in cortex potentially 
leading to increased motor activity.  
 
3.7 Implications for overall brain metabolism 
The current findings implicate that metabolic pathways within the brain are not equally 
used by all cell types. Rather, feeding a ketogenic diet highlights the 
compartmentalization of brain metabolism between different cell types. From the current 
findings we propose the following hypothetic model by which different cell types could 
interact under ketogenic conditions to contribute to overall brain metabolism (Fig. 35). 
Under ketogenic conditions, glycolytic endothelial cells rely on the continuous supply of 
glucose from the blood thereby maintaining normal glycolytic rate. To support brain 
metabolism in response to KD feeding they facilitate transport of metabolic substrates 
like KB and fatty acids as alternative to glucose that is low abundant. Astrocytes switch 
to utilization of KB and fatty acids transported from the circulation by endothelial cells. 
By relying on fatty acid and KB breakdown under ketosis astrocytes are able to provide 
residual glucose for neurons, which are to a certain extent dependent on sufficient 
glucose supply. Neurons might take up glucose via GLUT3 from the extracellular space 
and from astrocytes and fuel glycolysis. This explains why no alterations in glycolysis 
could be observed on global cortical level. While astrocytes decrease glycolysis neurons 
enhance it, thereby compensating the reduced glucose consumption of astrocytes. 
However, both cell types might contribute equally to increased abundance of SCOT 





neurons might lead to increased energy production. KD feeding also increased synaptic 
transmission in neurons probably supported by enhanced energy levels in these cells. In 
contrast, oligodendrocytes do not increase ketolysis. Rather they might supply KB to 
axons by shuttling these substrates through MCT1 and facilitate ion homeostasis and 





Fig. 35: Hypothetic model of metabolic changes in brain cells upon ketogenic diet 
feeding in mice 
By feeding a ketogenic diet, the blood composition of metabolites changes to increased levels 
of ßOHB and fatty acids, while glucose decreases. Endothelial cells (pink) seem to decrease 
mitochondrial respiration and rely on glycolysis. However, astrocytes (blue) take up increased 
amounts of ßOHB via MCT1 and fatty acids to support ketolysis and ß-oxidation, respectively 
for energy production. In addition, glucose is taken up into astrocytes through GLUT1 but 
probably is rather shuttled to neurons than utilized within astrocytes via glycolysis. On the other 
hand, oligodendrocytes (green) does not change their metabolism in response to the ketogenic 
diet, but might take up ßOHB to pass it on to neurons. As the main consumer of the brain, 
neurons (yellow) take up ßOHB delivered through astrocytes and oligodendrocytes to generate 
energy via ketolysis and subsequent mitochondrial respiration. In addition, through increased 
expression of GLUT3 neurons are able to increase the uptake of glucose even under short 
supply conditions. This leads in turn to increased glycolysis and might end in enhanced 
neuronal synaptic transmission. Gluc=Glucose; FA= Fatty acids; ßOHB= ß-hydroxybutyrate; 
GLUT1/3= Glucose transporter 1/3; MCT1= Monocarboxylate transporter 1 





4 Material and Methods 
4.1 Material 
 
If not stated otherwise, the used chemicals were provided by Sigma-Aldrich GmbH 
(Munich, Germany) or SERVA (Heidelberg, Germany). Laboratory materials and 
equipment were purchased from BD Falcon (Heidelberg, Germany), Bio-Rad (Munich, 
Germany), Sartorius (Göttingen, Germany), Gilson (Limburg-Offheim, Germany), Brand 
(Radebeul, Germany) or Eppendorf (Hamburg, Germany).  
 
4.1.1 General laboratory equipment 
4.1.1.1 Animal treatment 
Freestyle Precision System  Abbot Diabetes Care 
Rearing devices (shelf and box) Custom made (In-house) 
 
4.1.1.2 Molecular Biology 
Agilent 2100 Bioanalyzer Agilent 
Light Cycler 480 II Roche 
PowerPac 300 Power Supply Bio-Rad 
SDS-PAGE gel casting/running units Bio-Rad 
Eon Microplate Spectrophotometer BioTek 
Table-top Thermomixer Eppendorf 
Table-top Centrifuge Eppendorf 
INTAS ChemoCam Imager ECL HR-16-3200 Intas 
Ultra Turrax T8 homogenizer Kinematica 
Invitrogen semi-dry blotter Invitrogen 
Invitrogen wet-blot system Invitrogen 
 
4.1.1.3 Histology 
Leica Jung Cryocut CM3000 Leica 
Embedding station HMP110 Microm 
Paraffin embedding center AP280 Microm 
Sliding microtome HM400 Microm 
Microwave inverter Panasonic 
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Biowave Pro Pelco 
 
4.1.1.4 Tissue dissection 
Razor blades Persona 
Dumont forceps Fine Science Tools 
Standard scissor Fine Science Tools 
Fine iris scissor Fine Science Tools 
 
4.1.1.5 Cell Isolation 
Octomacs magnet Miltenyi Biotech 
Stand for Octomacs Miltenyi Biotech 
Water bath Hecht Assistent GmbH 
Sorvall wX+ Ultra Series centrifuge Thermo Scientific 
Ultra centrifuge rotor Th660 Thermo Scientific 
Labofuge 400 Heraeus instruments 
 
4.1.1.6 Electron microscopy 
EM Trimm Leica 
Ultracut S Leica 
Semi 35° diamond knife Diatome 
Ultra 45° diamond knife Diatome 
 
4.1.1.7 Microscopes 
Axio Oberserver Z1 Zeiss 
Leo EM900 electron microscope Zeiss 
Leica SP8X FALCON Leica 
 
4.1.1.8 Behavior 




Adobe Illustrator CC 
ImageJ/Fiji 
GraphPad Prism6 




Microsoft Excel 2013 
Biobserve Viewer Software 
Matlab 
Zen 2012 Zeiss 
LASX Leica 
VANTED   
 
4.1.1.10 Consumables 
Syringe 1 ml BD Bioscience 
Venofix® 0.4x 10 mm Braun 
27 G cannula BD Bioscience 
Glucose test strips Abott Diabetes Care 
Ketone body test strips Abott Diabetes Care 
Cell strainer 70 µm BD Bioscience 
MS Columns Miltenyi Biotech 
HistoBond® slides Marienfeld 
Cover glass Assistant 
Tissue cassettes Polyscience Inc. 
Aqua-Poly/Mount Polyscience Inc. 
Tissue-Tek® O.C.T Compound VWR 
PVDF-Membrane Hybond-PTM Amersham 
Copper Grids Science Services 
Milk powder Frema 
 
4.1.1.11 Chemicals 
Goat serum Invitrogen 
Horse serum Sigma-Aldrich 
Bovine serum albumin (BSA) Biomol GmbH 
Dubelco’s phosphate buffered saline (DPBS) Gibco 
RLT buffer Qiagen 
 
4.1.1.12 Enzymes 
PhosStop phosphatase inhibitor Roche Diagnostics GmbH 
Complete Mini protease inhibitor Roche Diagnostics GmbH 
 




Agilent RNA 6000 Nano Kit Agilent 
DC Protein Assay (Lowry) Bio-Rad 
RNeasy Mini kit Qiagen 
SuperScript III Reverse Transcriptase  Invitrogen 
Western Lightning Plus ECL Perkin Elmer Life Sciences 
Adult brain dissociation kit Miltenyi Biotech 
Neuron cell isolation kit Miltenyi Biotech 
Anti-ACSA-2 MicroBead kit Miltenyi Biotech 
Anti-O4 MicroBead kit Miltenyi Biotech 
Anti-CD31 MicroBead kit Miltenyi Biotech 
 
4.1.2 Solutions and buffers 
4.1.2.1 1x Phosphate buffered saline (PBS)  
170 mM Sodium chloride (NaCl)  
3,4 mM Potassium chloride (KCL)  
4 mM di-Sodium hydrogen phosphate (Na2HPO4 x 2H2O) 
1,8 mM di-Potassium hydrogen phosphate (K2HPO4)  
Adjust to pH 7.2 with 1 N NaOH. 
 
4.1.2.2 Avertin 
2% [w/v] 2,2,2-Tribrome ethanol 99%  
2% [v/v] Amyl alcohol 
Mixed for 30 min at 40°C, filtered before stored at -20°C 
 
4.1.2.3 16% Paraformaldehyde (PFA, stock solution)  
16% [w/v] Paraformaldehyde 
Cooked at 65°C for 15 min while stirring, 5N NaOH was added until solution turned clear. 
Filtered and stored at -20C°. 
 
4.1.2.4 0.2 M Phosphate buffer  
0.36% [w/v] Sodiumdihydrogenphosphate (NaH2PO4)  
3.1% [w/v] di-Sodiumhydrogenphosphate (Na2HPO4)  
1% [w/v] Sodium chloride 
 




4.1.2.5 4% Paraformaldehyde  
25% [v/v] PFA (16% stock solution) 
50% [v/v] 0.2 M phosphate buffer  
0,8% [w/v] Sodium chloride (NaCl) 
 
4.1.2.6 Karlsson-Schultz (K+S) fixative for electron microscopy  
25% [v/v] PFA (16% stock solution) 
2.5% [v/v] Glutaraldehyde  
50% [v/v] 0.2 M phosphate buffer  
0,8% [w/v] Sodium chloride (NaCl) 
 
4.1.3 Buffer for immunohistochemistry 
4.1.3.1 Citrate buffer (0.01 M, pH 6.0)  
1.8 mM Citric acid (C6H8O7.H2O)  
8.2 mM Sodium citrate (C6H5O7Na3.2H2O)  
Always prepared freshly. 
 
4.1.3.2 Tris buffer (pH 7.6)  
50 mM Tris/HCl, pH 7.6  
0.9% [w/v] Sodium chloride (NaCl)  
Always prepared freshly. 
 
4.1.3.3 Tris buffered milk 
50 mM Tris/HCL pH 7.6 
2% [w/v] milk powder 
0.9% [w/v] Sodium chloride (NaCl) 
Stirred for 20 min and filtered before use. 
 
4.1.3.4 TE buffer 
10 mM Tris/HCL pH 9.0 
1 mM ethylenediaminetetraacetic acid (EDTA, C10H16N2O8) 
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4.1.3.5 30% Sucrose 
30% [w/v] Sucrose 
70% [v/v] 1x PBS pH 7.2 
 
4.1.3.6 BSA/PBS  
0.04 M Sodium di-hydrogen phosphate (NaH2PO4)  
0.16 M di-Sodium hydrogen phosphate (Na2HPO4)  
1.8% [w/v] Sodium chloride (NaCl) 
1.0% [w/v] Bovines serum albumin (BSA) 
 
4.1.4 Molecular biochemistry  
4.1.4.1 Sucrose buffer  
320 mM Sucrose  
10 mM Tris-HCl pH 7.4  
1 mM Sodium hydrogen carbonate (NaHCO3) 
1 mM Magnesium chloride (MgCl2) 
1 tablet of proteinase and phosphatase inhibitors were added to 10 ml of sucrose buffer. 
 
4.1.4.2 Running buffer  
25 mM TrisBase  
192 mM Glycine  
1% [w/v] Sodium deoxycholate (SDS) 
 
4.1.4.3 Transfer buffer  
48 mM TrisBase  
39 mM Glycine  
10 % [v/v] Methanol 
 
4.1.4.4 Tris buffered saline with Tween20 (TBST)  
50 mM Tris-HCl (pH 7.4)  
150 mM Sodium chloride (NaCl) 
0.05 % [v/v] Tween20 
 




4.1.4.5 4x loading dye  
40 % [w/v] Glycine  
240 mM Tris-HCl pH 6.8  
8 % [w/v] Sodium deoxycholate (SDS)  
0.04% [w/v] Bromphenole blue 
 
4.1.4.6 SDS separation gel  
10-16% [v/v] Acrylamide / Bisacrylamide 29:1  
0.4 M Tris-HCl pH 8.8  
0.1% [w/v] Sodium deoxycholate (SDS)  
0.03% [v/v] Ammonium persulfate  
0.08% [v/v] TEMED 
 
4.1.4.7 SDS stacking gel  
4% [v/v] Acrylamide / Bisacrylamide 29:1  
125 mM Tris-HCl pH 6.8  
0.1% [w/v] Sodium deoxycholate (SDS)  
0.05% [w/v] Ammonium persulfate  
0.1% [w/v] TEMED 
 
4.1.4.8 Lysis Buffer for proteomics  
7 M urea  
2 M thiourea  
10 mM DTT  
2% CHAPS 
0.1 M Tris pH 8.5 
 
4.1.4.9 Wash Buffer for proteomics  
8 M urea 
10 mM DTT, 
0.1 M Tris pH 8.5 
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4.1.5 Solutions for electron microscopy 
4.1.5.1 Epon (Epoxy resin) 
171.3 g Glycidether 100  
115 g DDSA (Dodecenyl succinic anhydride)  
89 g MNA (Methyl nadic anhydride)  
Mixed for 10 min before 6.5 ml DMP-30 was added. 
Mixed again for 20 min 
 
4.1.5.2 Formvar solution  
1.25% [w/v] Formvar  
50 ml Chloroform  
Mixed for 30 min and stored protected from light at RT. 
 
4.1.5.3 Reynolds lead citrate solutions  
1.33 g Lead nitrate (N2O6Pb) 
1.76 g Sodium citrate (Na3C6H5O7) 
Solved in 30 ml ddH2O while shaking. After 30 min 8 ml of 1 M NaOH was added to 
adjust the pH to 12. ddH2O was added to 50 ml. Solution was sterile filtered before use. 
 
4.1.5.4 Uranyl acetate  
4% [w/v] Uranyl acetate  
Filtered before use. 
 
4.1.6 qRT-PCR Primers 
Primer for qRT-PCR were synthetized by the AGCT-laboratory of the Max-Planck 
Institute of Experimental Medicine  
 
Acaca (Acc1) for: 5'-GGATGTGGATGATGGTCTGA-3' 
 rev: 5'-GGCCTTGATCATCACTGGAT-3' 
Acacb (Acc2) for: 5'-CACGAGATTGCTTTCCTAGGTC-3' 
 rev: 5'-GGTGGAGGCGATCTTGTC-3' 
Bdnf for: 5'-GCATCTGTTGGGGAGACAAG-3' 
 rev: 5‘-TGGTCATCACTCTTCTCACCTG-3‘ 
Fasn for: 5'-GTCCACCCCAAGCAGGCACA-3' 




 rev: 5'-ACTCACACCCACCCAGACGC-3' 
Hk1 for: 5'-GTGGACGGGACGCTCTAC-3' 
 rev: 5'-TTCACTGTTTGGTGCATGATT-3' 
Mbp for: 5'-CCTCAGAGGACAGTGATGTGTTT-3' 
 rev: 5'-AGCCGAGGTCCCATTGTT-3' 
Mog for: 5'-GTTGACCCAATAGAAGGGATCTT-3' 
 rev: 5'-CTTCTTCAGAGACCACTCTTACCA-3' 
Mlycd (Mcd) for: 5'-TGGTCAAGGAGCTGCAGAA-3' 
 rev: 5'-TAGGCGACAGGCTTGAAAAG-3' 
Rplp0 for: 5’-GATGCCCAGGGAAGACAG-3‘  
 rev: 5’-ACAATGAAGCATTTTGGATAATCA-3’ 
Rps13 for: 5’-CGAAAGCACCTTGAGAGGAA-3’ 
 rev: 5’-TTCCAATTAGGTGGGAGCAC-3’ 
Slc2a1 (Glut1) for: 5'-GACCCTGCACCTCATTGG-3' 
 rev: 5'-GACCCTGCACCTCATTGG-3' 
Slc16a1 (Mct1) for: 5'-ATGCTGCCCTGTCCTCCT-3' 
 rev: 5'-CCACAAGCCCAGTACGTGTAT-3' 
Slc16a3 (Mct4) for: 5’-TTGTGGGTGGCCTCTTTG-3’ 
 rev: 5‘-TGAGAGCCAGACCCAAGC-3‘ 
Slc16a7 (Mct2) for: 5'-TCGTGGAGTGTTGTCCAGTT-3' 




Antigen Host  Application  Vendor 
ACAT1 Polyclonal rabbit WB 1:5000 Proteintech 
Actin Monoclonal Mouse WB 1:2500 Millipore 
CNP Monoclonal Mouse Cryo IHC: 1:5000 Atlas Antibodies 
BDH1 Polyclonal rabbit WB 1:500 Proteintech 
GLUT1 Polyclonal rabbit WB 1:5000 Custom made 
Isolectin IB4  Cryo IHC 1:50 Vector Lab 
MBP Polyclonal rabbit Paraffin IHC 1:200 Custom made 
MCT1 Polyclonal rabbit WB 1:1000 
Paraffin IHC 1:100 
Custom made 
NeuN Monoclonal Mouse Cryo IHC 1:100 Chemicon 
S100ß Polyclonal rabbit Paraffin IHC 1:200 Abcam 
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SCOT Polyclonal rabbit WB 1: 1000; 




Antigen Host  Application  Vendor 
α-rabbit-HRP Goat WB 1:5000 Dianova 
α-mouse-HRP Goat WB 1:5000 Dianova 
α-mouse-Alexa 488, 555 Donkey IHC 1:1000 Invitrogen 
α-rabbit-Alexa 488, 555 Donkey IHC 1:1000 Invitrogen 
 
  







All experiments were performed in accordance with the animal policies of the Max Planck 
Institute of Experimental Medicine (MPI-EM) and approved by the German Federal State 
of Lower Saxony. Mice used in this study were bred and kept at the animal facility of the 
MPI-EM at a 12/12 light-dark cycle. 5 male C57/N mice were housed together with ad 
libitum access to food and water. Maternal production of milk can be impaired by feeding 
ketogenic diets (Sussman et al., 2013). To achieve normal lactogenesis of damns while 
rearing mice solely on ketogenic diet, food separation for damns and pups was 
implemented. At the age of P10 of pups, a second shelf was installed into the cage with 
liquefied standard chow (65% ssniff V1124 and 35% ssniff E15712-10) for damns. At 
P14, ketogenic (KD, ssniff E15249-30) or normal chow (SD, ssniff V1124) for control 
animals was administrated in boxes with small holes making it only accessible for pups. 
Mice were weaned at P17 and kept on the respective diet. Measurement of blood 
glucose, ketone bodies and bodyweight were performed between 10-12 a.m. Blood were 
taken from tail tip and measured using the Freestyle Precision System with respective 
strips for glucose or ß-hydroxybutyrate (Abbott Diabetes Care, Wiesbaden, Germany). 
Mice were sacrificed by cervical dislocation or perfusion after anesthesia with Avertin. 
 
4.2.2 Protein biochemistry 
4.2.2.1 Tissue extraction for protein and RNA isolation 
Tissue was snap frozen on dry ice and stored at -80°C until further processing. Frozen 
cortices were homogenized in 600 µl sucrose buffer using the Ultraturrax (T8, Ika, 
Staufen, Germany) at maximum speed for 30 sec. For RNA isolation 100 µl lysate were 
mixed with 600 µl RLT and stored at -20°C. For protein biochemical analysis detergents 
were added to a final concentration of 2% lithium dodecylsulfate (LDS), 1% TritonX-100 
and 1% sodium deoxycholate. Samples were stored at -80°C for until further processing.  
 
4.2.2.2 Determination of protein concentration 
Protein concentration was determined using the Bio-Rad DCTM Protein Assay kit (Bio-
Rad Laboratories GmbH, Munich, Germany) according to manufacturer’s instructions. 
The principle is based on the well-established Lowry assay. Optical density for each 
sample was measured in triplicates at 650 nm using an Eon microplate 
spectrophotometer (BioTek Instruments GmbH, Bad Friedrichshall, Germany). A BSA 
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standard curve with known protein concentration (0-3µg/µl) was used to calculate sample 
concentration accordingly. Protein samples were adjusted to equal amounts in 1x SDS 
loading buffer containing 5% ß-mercaptoethanol and stored at -20°C. 
 
4.2.2.3 Separation of Proteins by SDS-PAGE 
Homogenates were denaturated for 10 min at 40°C on a shaker. Freshly prepared SDS-
polyacrylamide gels (10-16%) were loaded with 1-10µg of total protein lysate 
corresponding to respective protein size and antibody conditions. 5 µl PageRulerTM Plus 
Prestained Protein ladder (ThermoFischer) was used as marker. Protein separation was 
achieved according the protocol established by Laemmli (Laemmli, 1970) using the Bio-
Rad system and power supply. Proteins were separated according to their size for 1h at 
200V. Gels were stored in 1x transfer buffer until further processing. 
 
4.2.2.4 Immunoblot 
Proteins were transferred to methanol activated polyvinylidene difluoride (PVDF) 
membranes (Hybond P, biosciences) according to Towbin and colleagues (1979) using 
the Invitrogen semi-dry chamber (Karlsruhe, Germany). Membranes were activated for 
1 min in 100% methanol, washed with ddH2O and stored in 1x transfer buffer. Four 
Whatman papers incubated in transfer buffer were put onto the anode plate. The 
activated PVDF membrane was layered on top, followed by the gel and four additional 
Whatmann papers. Proteins were transferred for 40 min at 20 V.  
For transfer of hydrophobic proteins (MCT1, GLUT1) wet-chamber immunoblotting 
(Invitrogen) was used. Therefore, three sponges soaked in 1x transfer buffer were put 
into the wet-chamber followed by two Whatman papers, the activated PVDF membrane 
and the gel. On top, two Whatman papers and three sponges were layered. The wet-
chamber was closed and filled with 1x transfer buffer. Gels were blotted for 1 h at 38 V. 
Subsequently, membranes were blocked in TBS-T with 5% milk powder. Primary 
antibody incubation was carried out over night at 4°C while rotating. To avoid staining of 
unbound primary antibody, membranes were washed three times for 5 min in TBS-T. 
HRP-conjugated secondary antibody incubation was carried out at RT for 45 min. 
Membranes were washed again three times in TBS-T for 5 min before signal detection. 
For protein detection, the Western Lightning Plus-ECL-Kit (Perkin Elmer Life Sciences) 
was used. 1 ml of the reagent was applied to the membranes for 1 min for 
chemiluminescence detection with the Intas ChemoCam Imager for 1-15 min. 
Membranes were controlled for equal protein loading by detection of actin as loading 
control. Signals were analyzed with ImageJ Software and normalized to the loading 




control. Values were displayed as histograms and p-values were calculated using the 
Student’s t-test.  
 
4.2.3 RNA isolation and analysis 
4.2.3.1 RNA isolation 
To isolate RNA from cortex the RNeasy Mini Prep kit (Quiagen, Hilden, Germany) was 
used following manaufacturer’s instructions. Homogenized tissue was added with one 
volume (700 µl) 70% ethanol and vortexed vigorously. One volume was pipetted onto 
RNeasy Mini Spin columns and centrifuged for 1 min at 13.000 rpm. Flow through was 
discarded and the second volume was processed as described above. 700 µl RW1 
buffer was added onto the column and centrifuged for 1 min at 13.000 rpm. After 
discarding the flow through and collection tube 500 µl RPE buffer was added and 
centrifuged for 1 min at 13.000 rpm. This step was repeated before drying the columns 
by centrifugation for 2 min at 13.000 rpm. To elute the RNA 30 µl of RNA grade H2O was 
pipetted directly onto the column membrane and centrifuged for 1 min at 13.000 rpm. 
This step was repeated afterwards and eluted RNA was stored at -80°C.  
 
4.2.3.2 RNA concentration measurement and quality control  
To determine the quality and concentration of samples, RNA was measured using the 
Agilent RNA 6000 Nano Kit together with the Agilent 2100 Bioanalyzer (Agilent, Santa 
Clara, United States) following manufacturer’s instructions. Samples with a RNA integrity 
number of 8.5 or higher were used for further synthesis of cDNA. 
 
4.2.3.3 cDNA synthesis 
For analysis of RNA expression profiles, isolated RNA from cortex samples was 
converted to a single strand of complementary DNA (cDNA). Based on a reverse 
transcription reaction, cDNA was synthesized by RNA dependent DNA polymerase 
SuperScript III (Invitrogen, Karlsruhe, Germany). In a first step a RNA-primer mix was 
prepared using: 
 
4 µl RNA (500-1000 ng) 
1 µl dT Primer mix (0.6 pmol/µl) 
1µl N9 (random nonamers 120 pmol/µl) 
This mix was incubated for 2 min at 70°C to denaturate RNA and primers and stored on 
ice while preparing the second premix containing: 
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2 µl 5x first strand buffer 
0.5 µl dNTP (10 mM) 
1 µl DTT (100 mM) 
1 µl SuperScript III reverse transcriptase (200 U/µl) 
 
The final reaction mixture of 10.5 µl was centrifuged and incubated in a thermocycler 
with the following protocol:  
 
25°C 10 min 
50°C 45 min 
55°C 45 min  
 
Synthesized cDNA was diluted with ddH2O to a final concentration of 5 ng/µl. 
 
4.2.3.4 Quantitative real time polymerase chain reaction (qRT-PCR) 
qRT-PCR was carried out using the SybrGreen Mix (Promega, Mannheim, Germany) on 
the Light Cycler 480 II (Roche, Mannheim, Germany). Primer were selected using the 
Universal Probe Library (https://liefescience.roche.com) and checked against unspecific 
off- targets by using the NCBI Primer-blast tool 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/). For the PCR reaction the following 
reaction mix was prepared (in three technical replicates):  
 
2 µl cDNA 
5 µl SybrGreen 
0.4 µl forward primer (10 pM) 
0.4 µl reverse primer (10 pM) 
2.2 µl ddH2O 
 
The PCR reaction was performed using the following temperature conditions: 
 
50°C 2 min 
95°C 10 min 
45x cycle: 95°C 15 sec 
      60°C 1 min 
 
Raw data were analyzed using the Light Cycler® software 1.5.0SP4 and cycle thresholds 
(CT) values were calculated from the technical replicates. To account for differences in 




cDNA input, CT values were normalized to the geometric mean of the housekeeping 
genes Rplp0 (60s acidic ribosomal protein P) and Rps13 (Ribosomal protein s13) and 
analyzed by the ∆∆CT method (Pfaffl, 2004). Results were displayed as histograms 
normalized to levels of SD fed animals that were set to 1 using GraphPad Prism6. P-
value quantification was performed using the Student’s t-test. 
 
4.2.4 Immunohistochemistry 
4.2.4.1 Perfusion and tissue fixation 
Mice were deeply anesthetized by intraperitoneal injection of avertin (0.2 ml/10 g of body 
weight). Successful anesthesia was confirmed by paw pinch test. To expose the heart, 
the abdomen was opened and the diaphragm was removed. A butterfly cannula (27G, 
Venofix) of a peristaltic pump was injected intracardial and the right atrium was opened. 
The blood was flushed out with PBS until the liver was decolorized. For cryo-sectioning 
the brain was postfixed over night in 4% PFA. To fixate the tissue for paraffin embedding 
4% PFA was used for 10 min at a pump rate of 1.5 ml/min (K+S for ultrastructural 
analysis, respectively). Tissue was dissected and stored over night at 4°C in the 
respective fixative.  
 
4.2.4.2 Immunohistochemistry of paraffin embedded tissue 
After fixation of tissue with 4% PFA, brains were embedded in paraffin (Paraplast, Leica, 
Wetzlar, Germany) with an automated embedding system (HMP 110, MICROM) using 
the following program steps:  
 
Procedure  Time 
50% Ethanol  1 h 
70% Ethanol  2x 2 h 
96% Ethanol  2x 2 h 
100% Ethanol  2x 2 h 
Isopropanol  1 h 
Xylol   2x 2 h 
Paraffin  2x 2 h 
  
Samples were arranged in metal forms and embedded with 60°C warm paraffin to cast 
blocks using the MICROM AP 280 Embedding station. Paraffin blocks were stored at RT 
and 5 µm thick sections were cut using the MICROM HM 400 microtome. Sections were 
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mounted on slides and dried over night at 37°C. Prior to staining, sections were 
deparaffinized by the following steps: 
 
Procedure   Time 
60°C    10 min 
Xylol    2x 10 min 
Xylol/Isopropanol (1:1) 10 min 
100% Ethanol   5 min 
90% Ethanol   5 min 
70% Ethanol   5 min 
50% Ethanol   5 min 
ddH2O    5 min 
 
4.2.5 Immunolabeling of paraffin embedded tissue 
For fluorescent labeling of paraffin embedded tissue, deparaffinized sections were 
incubated in citrate buffer (pH 6) for 5 min at RT followed by cooking in the same for 
10 min using a microwave (650 W) for antigen retrieval. Sections were allowed to cool 
down to RT for about 20 min and washed with Tris buffer containing 2% milk powder for 
5 min. Samples were transferred to a chamber filled with wet tissue paper to avoid a dry 
out. To prevent unspecific labeling of the primary antibody, sections were blocked for 
30 min with 20% goat serum in PBS/BSA at RT. Primary antibodies were diluted 
according to their final concentration in PBS/BSA and sections were incubated over night 
at 4°C. After subsequent washing steps with Tris buffer containing 2% milk, samples 
were incubated for 60 min at RT with the corresponding fluorescently labeled secondary 
antibody. As a general nuclear counterstain, DAPI was added to the secondary antibody 
dilution. Sections were washed with Tris buffer (without milk) and then mounted with 
Aquapolymount. 
 
4.2.5.1 Fluorescent labeling of cryosections. 
After postfixation of tissue in 4% PFA overnight, sagittal cut hemispheres were 
transferred into 30% Sucrose for 3 days for cryoprotection. Tissue was embedded in 
Tissue-Tek® (O.C.T.™ Compound, Sakura) and frozen on dry ice. 14 µm thick sections 
were cut using a Cryotome (Leica CM 1950, Leica, Wetzlar, Germany), mounted on 
slides and stored at -80°C until further use. Prior to staining sections were dried for 
30 min at 37°C and washed twice with PBS. Permeabilization was performed in 0.4% 
Triton (in PBS) for 30 min at RT. To avoid unspecific staining, sections were blocked for 




additional 30 min in 4% horse serum, 0.2% Triton in PBS. Primary antibodies were 
diluted according to their final concentration in 1% horse serum, 0.05% Triton in PBS. 
Sections were incubated with primary antibodies over two days. After primary antibody 
incubation, slides were washed twice with PBS. Secondary antibodies were diluted 
according to their final concentration in 1.5% horse serum in PBS containing DAPI 
(1:20000) and slides were incubated for 2 hours at RT. Prior to mounting slides with 
Aqua-poly-mount, slides were washed twice with PBS. 
 
4.2.5.2 Confocal microscopy of fluorescently labeled cryosections 
Confocal laser scanning microscopy was performed using a Leica SP8X FALCON 
equipped with a 63x/1.3 HC PL APO glycerol objective controlled by using the LASX 
software (Leica Microsystems). Pictures were taken randomly from layer V-VI of the 
cortex above the rostral corpus callosum with a 5.45x magnification. Signal detection 
was performed sequentially to avoid cross bleeding of different filter sets. Noise detection 
was reduced by 2x line averaging. Pictures were taken as z-stack with spatial z-
resolution of 190 nm. Deconvolution was achieved during picture processing using the 
LIGHTNING package of the LASX software. Pictures were displayed as maximum-
intensity projection and equally adapted for brightness and contrast using FIJI. 
 
4.2.6 Electron microscopy 
4.2.6.1 Tissue embedding 
K+S fixed tissue was placed into small plastic chambers filled with 0.1 M phosphate 
buffer, before embedding for subsequent EM imaging. An automated system (EMTP, 
Leica, Wetzlar, Germany) was used. Chambers were placed into the machine and 
samples were processed using the following protocol: 
 
Procedure   Time 
Phosphate buffer  3x 10 min 
2% OsO4   4 h 
ddH2O    3x 10 min 
30% Ethanol   20 min 
50% Ethanol   20 min 
70% Ethanol   20 min 
90% Ethanol   20 min 
100% Ethanol   4x 10 min 
Propylenoxid   3x 10 min 
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Propylenoxid/Epon 2:1 2 h 
Propylenoxid/Epon 1:1 2 h 
Propylenoxid/Epon 1:2 4 h 
Epon    4 h 
 
Afterwards samples were then placed into Epon filled molds and incubated over night at 
60°C for polymerization. 
 
4.2.6.2 Sectioning of Epon embedded tissue 
For electron microscopic analysis of cortex myelination, epon embedded cortex samples 
were trimmed 450 µm (step size 1 µm) on a microtome (Ultracut S, Leica, Wetzlar, 
Germany) using a diamond knife (Diatome Ultra 45°) starting from the pia mater to 
achieve the same sample region of interest. Ultra-thin sections (50 nm) were cut with a 
Diatome Ultra 35° and collected on formvar polyvinyl-coated copper grids. Sections were 
contrasted with 2% uranylacetate for 30 min followed by 1% lead citrate solution for 
12 min. After several washing steps with ddH2O, grids were dried with a filter paper. 
 
4.2.6.3 Electron microscopic analysis 
Ultra-thin sections were analyzed with a Zeiss EM900 electron microscope (Zeiss, 
Oberkochen, Germany) equipped with a wide-angle dual speed 2K-CCD-Camera (TRS, 
Moorenweis, Germany). Per sample 10 pictures at a magnification of 7500x were taken. 
G-ratio measurements and quantification of axon caliber distribution were performed 
using the grid tool (2x2 µm) from ImageJ according to the hit-to-point method. Student’s 
t-test was performed using GraphPad Prism6 and results were displayed with Adobe 
Ilustrator CS6.  
 
4.2.7 Metabolite Profiling  
Due to its rapid dynamics the metabolome is very difficult to measure (Jove et al., 2014) 
and postmortem degradation of metabolites frequently occurs (Sugiura et al., 2014). To 
overcome these difficulties, tissue extraction needed to be timed exactly and microwave 
irradiation was used to keep postmortem degradation to a minimum. Therefore, mice 
were sacrificed by cervical dislocation and decapitated. After exactly 12 s the head was 
transferred into a microwave (Biowave Pro, Pelco, Garching Germany) and exposed to 
microwave irradiation at 750 W for 16 s. The brain was extracted and transferred on ice. 
The cortex was dissected using a sagittal brain matrix. Tissue was snap frozen on dry 
ice exactly after 10 min and stored at –80°C until further processing. 




Metabolomic analysis was performed in collaboration with Dr. Till Ischebeck from the 
department of Plant Biochemstry at the University of Göttingen. Both the metabolites and 
sterols were measured from the same samples by gas-chromatographic-mass 
spectrometry GC/MS after extraction and derivatization as described by (Rotsch et al., 
2017). In brief, prior to extraction, tissue was lyophilized and dry weight was measured. 
.Cortices were ground to a fine powder using a beatmill (Retsch, Haan, Germany) and 
glass beads (5 mm, Carl Roth, Karlsruhe Germany) and extracted with 500 µl 
methanol:chloroform:water 129:50:25 [v/v/v]. Phase separation was induced by addition 
of the internal standard (250 µl 5 µg/ml allo-inositol in water). For the analysis of small 
metabolites, 100-200 µl of the upper aqueous phase was evaporated and metabolites 
were transformed into their methoxyimino (MEOX)- and trimethylsilyl (TMS)- derivatives 
by incubating overnight after addition of 15 µl methoxyamine hydrochloride and for 2-
10 h after addition of 30 µl N-metyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA). 1 µl of 
sample were injected per run. Each sample was analyzed with a longer a split of 1:10 to 
1:50 on an Agilent 5977N mass selective detector connected to an Agilent 7890B gas 
chromatograph equipped with a capillary HP5-MS column (30 m x 0.25 mm, 0.25 µm 
coating thickness, Agilent Technologies). The inlet temperature was set to 280°C and a 
temperature gradient was applied (50°C for 2 min, 50 – 330°C at 5 K/min, 330°C for 2 
min). A transfer line of 330°C was used. Spectra recording was performed in the range 
of m/z = 71-600. GC/MS data were analyzed using the Agilent MSD ChemStation data 
analysis software (Agilent Technologies). In case that derivatization of metabolites led to 
several ion peaks of interest, abundance of the total ion count (TIC) of the individual 
analytes was added. The abundance of identified metabolites was normalized to the 
internal standard and to the dry weight of the sample.   
Sterols were extracted from the organic phase by adding 800 µl of MTBE:MeOH (v/v) 
and 200 µl of 0.9 % NaCl and 40 µl 17:0 fatty acid (0.25 mg/ml in chloroform). Each 
sample was measured twice. One time, 10 µl of the organic phase was used and run 
later with a 1:50 split to measure cholesterol. The second time, 50 µl of the organic phase 
was used and run later with a 1:10 split to measure other sterols. All samples were dried 
by N2 stream and re-dissolved in 15 µl pyridine. 30 µl of MSTFA was added followed by 
an incubation time of 2-10 h. Sterols were measured by GC/MS using the same set-up 
as described for small metabolites except for the temperature gradient, which was run at 
180°C for 1 min, 180 – 320°C at 5 K/min, 320°C for 5 min. The abundance of sterols was 
compared based on their TIC. Statistical evaluation was performed in R with the DESeq2 
package (Love et al., 2014) to account for multiple testing (performed by Ting Sun, MPI 
for experimental Medicine, Göttingen) 
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4.2.8 Open field test  
The open field test was performed as previously described (Babaev et al., 2016). Briefly, 
exploratory activity in a novel environment was tested in a gray arena (50x50 cm, 
surrounded by a wall of 50 cm height) at 20 lux light intensity. Individual animals were 
placed into one corner of periphery of the open field and allowed to explore it for 10 min. 
The exploratory behavior of the mouse was recorded using an overhead camera system 
and scored automatically using the Viewer software (Biobserve, St. Augustin, Germany). 
The overall traveled distance was analyzed as a parameter of general activity. Time, 
distance and visits in the center area was analyzed to measure anxiety behavior. Results 
were displayed as histograms and two-way ANOVA with Sidak’s post test was used for 
statistical significance using GraphPad Prims6 
 
4.2.9 Audiobox 
Audiobox experiments were done in collaboration with Dr. Livia de Hoz from the 
neurogenetics department of the MPI-EM. 
To assess learning ability of ketogenic fed mice, sound frequency discrimination was 
carried out in an Audiobox (TSE, Germany), based on an established protocol(Cruces-
Solis et al., 2018). Briefly, a sterile transponder (ISO compliant 11784 transponder, 
12 mm long, TSE, Germany) was implanted subcutaneously in the back of the isoflurane 
anaesthetized mice. The injection wound was closed using topical skin adhesive 
(Histoacryl, Braun, USA). This enables individual identification of mice and the behavior 
(nose-poking, licking) of each mouse can be detected. The Audiobox consists of the 
living area, where food can be accessed ad libitum and the Audiobox itself were water is 
supplied and frequency discrimination is performed. Both parts were connected through 
a corridor. Entrance into the Audiobox (visit) was detected by an antenna that reads the 
implanted transponder and a temperature sensor. The mouse can access water by nose-
poking into one of the two ports, which can be opened or closed according to the demand 
of the experiment. For the presentation of different sounds, a loudspeaker was positioned 
behind the Audiobox. Sounds were generated using Matlab (Mathworks). During the 
whole experiment one frequency (6.67kHz) was considered “safe”: if this frequency was 
presented during a visit, mice could drink without negative result. The “conditioned 
frequency” (13.34 kHz) was associated with an air-puff if a mouse nose-poked to get 
access to water. Therefore, mice had to learn to avoid nose-poking during a “conditioned 
visit”. During the habituation phase only the safe sound was presented. On day 1-2 ports 
were open and mice were drinking freely. The ports were closed on day 3-5 and only 
opened after the mouse nose-poked into the port. At day 6-9 (conditioning phase) the 




conditioned sound was presented in a small percentage of visits: 5% (day 6-7) or 10% 
(day 8-9). Nose-poking during a visit with the conditioned frequency resulted in the 
delivery of an air-puff and no opening of the water ports.  
 
4.2.10 Serum protein identification  
Identification of serum proteins was performed in collaboration with Dr. Olaf Jahn from 
the proteome facility of the MPI-EM according to (Ott et al., 2015). Briefly, gel 
electrophoresis for MS protein identification was performed on precast TG PRiME 
Tris/glycine 10% gels (Serva) according to manufacturer’s instructions (Invitrogen). 
Proteins were visualized using colloidal Coomassie staining. Gel bands of interest were 
excised manually and subjected to automated in-gel digestion with trypsin. Nanoscale 
reversed-phase UPLC separation of tryptic peptides was performed with a nanoAcquity 
UPLC system equipped with a Symmetry C18 trap column (5 µm, 180 µm x 20 mm) and 
a BEH C18 analytical column (1.7 µm, 75µm x 100mm) (Waters Corporation). Peptides 
were separated at a flow rate of of 300 nl/min with a linear gradient of 1% to 45% mobile 
phase B (acetonitrile containing 0.1% formic acid) while mobile phase A was water 
containing 0.1% formic acid for 45 min. Mass spectrometric analysis of tryptic peptides 
was performed as described below. 
 
4.2.11 Cell isolation from adult mouse brain 
Cells were isolated according to the Adult Brain Dissociation protocol (Miltenyi Biotec 
GmbH, Bergisch Gladbach, Germany) with minor modifications. In brief, brains were 
dissected and meninges removed with Whatman paper. For isolation of 
oligodendrocytes, astrocytes or endothelial cells, one single cortex per sample was 
isolated using a brain matrix, sliced in small pieces and stored in a round bottom tube 
with appropriate amount of enzyme mix 1 on ice. For isolation of neurons two cortices 
per sample were used. As not stated otherwise every step was performed on ice and 
centrifugation steps were performed at 300xg for 10 min at 4°C. After adding enzyme 
mix 2, tubes were incubated in a 37°C water bath for 30 min. Tissue were homogenized 
by gentle titruation during incubation. For subsequent steps DPBS without Mg2+ and Ca2+ 
were used as washing buffer. Cell suspension was passed through a 70 µm strainer, 
washed with 10 ml DPBS and centrifuged. Supernatant was discarded and the cell pellet 
was resuspended in 2 ml DPBS + 600 µl Debri Removal Solution. 1.4 ml DPBS were 
layered on top of the cell suspension prior to centrifugation at 3000xg for 10 min at 4°C 
with full acceleration/brake. The two top phases were discarded and the 15 ml Falcon 
tube were filled up with DPBS to 11 ml containing the remaining cell solution followed by 
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centrifugation at 1200xg for 10 min. Supernatant was discarded and cell pellet incubated 
in 1x Red blood cell removal solution. After 10 min 5 ml DPBS were added and the cell 
solution centrifuged. For magnetic cell labeling supernatant was discarded and cells 
resuspended in appropriate amount of DPBS according to the respective antibody 
Microbead kit protocol. Oligodendrocytes were labeled with 2.5 µl anti-O4 Microbeads 
for 15 min in 97.5 µl DPBS. Astrocytes were labeled with 10 µl anti-ACSAII Microbeads 
for 15 min after resuspending in 80 µl DPBS and incubation with 10 µl FcR-Blocking 
Reagent for 10 min. Endothelial cells were resuspended in 90 µl DPBS and labeled with 
10 µl anti-CD11b Microbeads for 15 min. To remove residual Microbeads 1 ml DPBS 
was added followed by centrifugation. Supernatant was discarded and labeled cells 
resuspended in 0.5 ml DPBS. MS Columns were attached to the Octomacs magnet and 
equilibrated with 0.5 ml DPBS. Labeled cells were pipetted onto the MS Columns and 
washed 3x with DPBS. Flow through was collected for further isolation of cell types. After 
washing, MS Columns were detached and cells eluted in 0.5 ml of respective Buffer or 
pelleted and stored at -80°C. 
Negative selection using the Neuron isolation kit was performed to isolate neuronal cells. 
Cells were resuspended in 200 µl DPBS and incubated with 20 µl Non-Neuronal Cell-
Biotin-Antibody Cocktail for 5 min. Cells were washed with 1 ml DPBS and centrifuged 
for 10 min at 300xg. After aspiration of supernatant, cells were resuspended in 200 µl 
DPBS and incubated with 20 µl Anti-Biotin Microbeads with additional 5 µl anti-O4 
Microbeads for 10 min. DPBS was added to 1 ml, cell solution was splitted and pipetted 
on two equilibrated MS Columns. Columns were washed three times with 0.5 ml DPBS. 
Flow through was collected and again pipetted on two MS Columns with repeated 
washing steps. Flow through was centrifuged for 2 min at 13000 rpm at 4°C to pellet 
isolated neurons. After aspiration of supernatant neurons were stored at -80°C. 
 
4.2.11.1 Proteome analysis of isolated cells 
Proteome analysis was performed in collaboration with Dr. Olaf Jahn and Lars Piepkorn 
from the proteome facility of the MPI-EM. 
 
4.2.11.1.1 Proteolytic digestion 
Isolated cell fractions from adult mouse cortex were dissolved in lysis buffer and 
processed according to a filter-aided sample preparation (FASP) protocol previously 
described (Ambrozkiewicz et al., 2018; Distler et al., 2014; Distler et al., 2016). If not 
mentioned otherwise, all steps were automated on a liquid-handling workstation 
equipped with a vacuum manifold (Freedom EVO 150, Tecan) using an in-house 




constructed adaptor device. In brief, samples were lysed and reduced by shaking for 
30 min at 37°C and loaded on centrifugal filter units (30 kDa MWCO, Millipore). 
Detergents were removed by washing twice with wash buffer. Using 50 mM 
iodoacetamide in 8 M urea/0.1 M Tris pH 8.5 for 20 min at RT, proteins were alkylated. 
Excess reagent was removed by washing twice in wash buffer. Exchange of buffer was 
achieved by three times washing with 50 mM ammonium bicarbonate (ABC) containing 
10% acetonitrile. Quantitative removal of liquids was ensured by centrifugation during 
three additional washing steps with 50 mM ABC/10% acetonitrile. Proteins were digested 
overnight at 37°C with 500 ng trypsin in 40 µl of the same buffer. Recovering of tryptic 
peptides was performed by centrifugation followed by two additional extraction steps with 
40 µl of 50 mM ABC and 40 µl of 1% trifluoroacetic acid (TFA), respectively. For 
quantification purposes, aliquots of the combined flow-throughs were spiked with 10 
fmol/μl Hi3 EColi standard (Waters Corporation) (Silva et al., 2006). Aliquots were 
analyzed by liquid chromatography coupled to electrospray mass spectrometry (LC-MS).  
 
4.2.11.1.2 LC-MS analysis 
Nanoscale reverse-phase UPLC separation of tryptic peptides was performed according 
to (Ambrozkiewicz et al., 2018) using an nanoAcquity UPLC system equipped with a 
Symmetry C18 5 μm, 180 μm × 20 mm trap column and a HSS T3 C18 1.8 μm, 75 μm 
× 250 mm analytical column maintained at 45 °C (Waters Corporation). Peptides were 
injected and trapped for 4 min at a flow rate of 8 µl/min 0.1 % TFA. Separation was 
performed at a flow rate of 300 nl/min for 180 min using a gradient comprised of two 
linear steps. Water containing 0.1% formic acid was increased in 165 min from 3-35% 
and acetonitrile containing 0.1% formic acid from 35-60% in the remaining 15 min. 
MS analysis of tryptic peptides was performed using a Synapt G2-S quadrupole time-of-
flight mass spectrometer equipped with ion mobility option (Waters Corporation) enabling 
acquisition of positive ions in a mass range of m/z 50 to 2000 at a minimum resolution of 
20000 FWHM (full width at half maximum). Analysis was performed as described by 
Distler et al. (2014; 2016). Continuum LC-MS data processing was achieved using 
Waters ProteinLynx Global Server (PLGS) version 3.0.2 (Li et al., 2009). Protein 
identification was performed using the UniProtKB/Swiss-Prot mouse proteome to which 
the sequence information for E. coli. Chaperone protein ClpB and porcine trypsin was 
added. Appending the reversed entry sequence enabled determination of false discovery 
rate (FDR). Precursor and fragment ion mass tolerances were automatically determined 
by PLGS 3.0.2. Carbamidomethylation of cysteine was set to fixed whereas oxidation of 
methionine was assumed as variable modification. One missed trypsin cleavage was 
allowed and minimal ion matching requirements was: two fragments/peptide, five 
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fragments/protein, one peptide/protein. Threshold of FDR protein identification was set 
to 1%. 
 
4.2.11.1.3 Experimental design and data analysis 
Experimental design and data analysis: Cell fractions from four cortices of standard and 
ketogenic diet fed mice at six weeks of age were used (two cortices/cell fraction for 
neuron isolation). Samples were processed with replicate digestion and injection, which 
resulted in two technical replicates per biological replicate (16 LC-MS runs in total per 
cell fraction). ISOQuant (http://www.isoquant.net) that is a freely available software was 
used for post-identification analysis based on the TOP3 quantification approach (Distler 
et al., 2014; Distler et al., 2016; Kuharev et al., 2015). Peptides had to have at least 
seven amino acids with a score above or equal to 5.5 to be considered. FDR threshold 
for peptides and proteins was set to 1% and only proteins with at least two peptides were 
quantified. The parts per million (ppm) abundance values were log2-transformed and 
normalized by subtraction of the median from all data points for the respective protein. 
Moderated t-statistics with an empirical Bayes approach including a FDR-based 
correction for multiple comparisons were used to detect significant changes in protein 
abundance (Kammers et al., 2015). Therefore, the Bioconductor packages “limma” 
(Ritchie et al., 2015) and “q-value” (Storey & Tibshirani, 2003) were used in RStudio. 
 
4.2.11.2 Transcriptomics 
Transcriptome analysis of isolated cells was performed in collaboration with Prof. Dr. 
Moritz Rossner and Nirmal Kannaiyan from the department of Psychiatry at the LMU 
Munich. 
 
4.2.11.2.1 Library Preparation 
Sequencing was performed with 4-5 biological replicates for each condition. RNA was 
extracted with the Qiagen Micro-Rneasy Kit (Qiagen, Cat. No. 74004) according to the 
manufacturer’s protocol. As external control, 1 l of ERCC RNA Spike-In Mix 
(ThermoFisher, Cat No. 4456740) diluted at 1:5000 was added to the isolated RNA. 
cDNA was synthesised with the Ovation RNA-Seq system v2 (NuGEN, Cat. No.7102). 
As input, 100 ng of cDNA was used for library preparation using the IonXpress plus 
gDNA and Amplicon library preparation kit (Thermofischer,cat no: 4471269). To achieve 
size selection of the library, a 2% E-Gel was used and the samples were barcoded and 
subsequently amplified. Further quantification for each sample library was performed 




using the Kapa Library Quantification Kit (Kapa, Cat. No. KK4827). Of each sample, 
equal amounts were sequenced on an Ion Torrent Sequencer. 
 
4.2.11.2.2 Transcriptome Data analysis 
Based on the barcodes, the raw reads (Fastq) were split into sample specific reads and 
subsequently checked for sequence quality and sequence repeats. Low quality bases 
and short reads were trimmed or excluded from further analysis. The reads were mapped 
to Mus musculus genome (mm10) using TMAP Aligner and quantified using Ensembl 
annotation 86 using Partek Flow software. Genes had to have at least 5 reads in at least 
80% of the samples to be considered for further analysis. Differentially expressed genes 
(DEGs) were determined in R with the DESeq2 package (Love et al., 2014). Genes with 
at least 0.5 fold change and adjusted pValue of less than or equal to 0.05 were 
considered as differentially expressed.  
 
4.2.11.2.3 Pathway analysis 
For analysis of relevant pathway enrichment in proteomic datasets the functional 
annotation tool DAVID was used (https://david.ncifcrf.gov/home.jsp) (Huang da et al., 
2009a, 2009b). All identified proteins of each cell fraction were uploaded as background 
to achieve more reliable p-value results. For each cell fraction significantly up or 
downregulated proteins were analysed differently. The threshold for target proteins were 
set manually for each cell fraction (Astrocytes: ≤ -1.0 log2FC; ≥ 0.5 log2FC, q-value ≤ 
0.0005; Oligodendrocytes: ≤ -0.25 log2FC; ≥ 0.25 log2FC, q-value ≤ 0.05; Endothelial 
cells: ≤ -0.25 log2FC; ≥ 0.25 log2FC, q-value ≤ 0.05; Neurons: ≤ -0.5 log2FC; ≥ 0.5 
log2FC, q-value ≤ 0.05). Analysis was performed based on KEGG and GO_BP direct 
terms. Only distinct pathways with a minimum count of 5 proteins and a p-value ≤ 0.05 
were considered for further analysis. For transcriptomic data the pre-defined affymetrix 
background from DAVID was used and the threshold for genes were set to ≤ -0.5log2FC; 
≥ 0.5 log2FC, padj-value ≤ 0.05. The remaining procedure was unaltered.  
Pathways were displayed either as heatmap depicting log2 fold changes of individual 
sample values of involved proteins or were visualized using VANTED version 2.6.5 
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List of full protein and gene names 
Protein  
ACAA1A 3-ketoacyl-CoA thiolase A 
ACAA1B 3-ketoacyl-CoA thiolase B 
ACAA2 3-ketoacyl-CoA thiolase 
ACADL Long-chain specific acyl-CoA dehydrogenase 
ACADM Medium-chain specific acyl-CoA dehydrogenase 
ACADSB Short/branched chain specific acyl-CoA dehydrogenase 
ACADVL Very long-chain specific acyl-CoA dehydrogenase 
ACAT1 Acetyl-CoA acetyltransferase 
ACC1 Acetyl-CoA carboxylase 1 
ACC2 Acetyl-CoA carboxylase 2 
ACLS1 Long-chain-fatty-acid-CoA ligase 1 
ACLS3 Long-chain-fatty-acid-CoA ligase 3 
ACLY ATP-citrate synthase 
ACO2 Aconitate hydratase 
ACOX1 Peroxisomal acyl-coenzyme A oxidase 1  
ACSBG1 Long-chain-fatty-acid-CoA ligase ACSBG1 
ACSL6 Long-chain-fatty-acid-CoA ligase 6 
ALB Albumin 
ALDH1L1 Cytosolic 10-formyltetrahydrofolate dehydrogenase 
ALDOA Fructose-bisphosphate aldolase A 
ALDOB Fructose-bisphosphate aldolase B 
ALDOC Fructose-bisphosphate aldolase C 
AP1B1 AP-1 complex subunit beta-1 
AP2A1 AP-2 complex subunit alpha-1 
AP2A2 AP-2 complex subunit alpha-2 
AP2B1 AP-2 complex subunit bet 
AP2M1 AP-2 complex subunit mu 
APOA1 Apolipoprotein A-I 
APOE Apolipoprotein E 
ARF5 ADP-ribosylation factor 5 
ATP2A2 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 
ATP2B4 Plasma membrane calcium-transporting ATPase 4 
ATP5F1 ATP synthase F(0) complex subunit B1 
ATP5F1B ATP synthase subunit beta 
ATP5F1C ATP synthase subunit gamma 
ATP5F1E ATP synthase subunit epsilon 
ATP5H ATP synthase subunit d 
ATP5J2 ATP synthase subunit f 
ATP5L ATP synthase subunit g 
ATP5O ATP synthase subunit O 
ATP6V0A1 V-type proton ATPase 116 kDa subunit a isoform 1 
ATP6V0C V-type proton ATPase 16 kDa proteolipid subunit 
ATP6V0D1 V-type proton ATPase subunit d 1 





ATP6V1B2 V-type proton ATPase subunit B_ brain isoform 
ATP6V1D V-type proton ATPase subunit D 
ATP6V1E1 V-type proton ATPase subunit E 1 
ATP6V1F V-type proton ATPase subunit F 
ATP6V1G1 V-type proton ATPase subunit G 1 
ATP6V1G3 V-type proton ATPase subunit G 3 
ATP6V1H V-type proton ATPase subunit H 
BDH1 D-beta-hydroxybutyrate dehydrogenase 
BSG Basigin 
CAPS1 Calcium-dependent secretion activator 1 
CLTA Clathrin light chain A 
CLTB Clathrin light chain B 
CLTC Clathrin light chain C 
CNP 2'_3'-cyclic-nucleotide 3'-phosphodiesterase 
COX4I1 Cytochrome c oxidase subunit 4 isoform 1 
COX5A Cytochrome c oxidase subunit 5A 
COX5B Cytochrome c oxidase subunit 5B 
COX6A1 Cytochrome c oxidase subunit 6A1 
COX6B1 Cytochrome c oxidase subunit 6B1 
COX6C Cytochrome c oxidase subunit 6C 
COX7A2 Cytochrome c oxidase subunit 7A2 
CPLX1 Complexin-1 
CPT1A Carnitine O-palmitoyltransferase 1_ liver isoform 
CPT2 Carnitine O-palmitoyltransferase 2 
CPLX2 Complexin-2 
CS Citrate synthase 
CYC1 Cytochrome c1_ heme protein 
DLD Dihydrolipoyl dehydrogenase 
DLST Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate 
dehydrogenase complex 
DNM1 Dynamin-1  
DNM2 Dynamin-2 
DNM3 Dynamin-3 
ECHS1 Enoyl-CoA hydratase 
ECI1 Enoyl-CoA delta isomerase 1 
ECI2 Enoyl-CoA delta isomerase 2 




FABP5 Fatty acid-binding protein_ epidermal 
FABP7 Fatty acid-binding protein_ brain 
FASN Fatty acid synthase 
FH1 Fumarate hydratase 
G6PD2 Glucose-6-phosphate 1-dehydrogenase 2 
G6PDX Glucose-6-phosphate 1-dehydrogenase X 




GLAST Glutamate aspartate transporter 
GLUT1 Glucose transporter 1 
GLUT3 Glucose transporter 3 
GPI Glucose-6-phosphate isomerase 
GYS1 Glycogen synthase 
HADH Hydroxyacyl-coenzyme A dehydrogenase 
HADHA Trifunctional enzyme subunit alpha 
HADHB Trifunctional enzyme subunit beta 
HK1 Hexokinase-1 
HK2 Hexokinase-2 
HKDC1 Putative hexokinase HKDC1 
ICAM2 Intercellular adhesion molecule 2 
IDH2 Isocitrate dehydrogenase [NADP] 
IDH3A Isocitrate dehydrogenase [NAD] subunit alpha 
IDH3G Isocitrate dehydrogenase [NAD] subunit gamma 1 
LDHA L-lactate dehydrogenase A chain 
LDHB L-lactate dehydrogenase B chain 
MBP Myelin basic protein 
MCT1 Monocarboxylate transporter 1 
MDH2 Malate dehydrogenase 
MTATP8 ATP synthase protein 8 
MTCO1 Cytochrome c oxidase subunit 1 
MTCO2 Cytochrome c oxidase subunit 2 
MT-CYB Cytochrome b 
MTND3 NADH-ubiquinone oxidoreductase chain 3  
MTND4 NADH-ubiquinone oxidoreductase chain 4 
MYOF Myoferlin 
NAPA Alpha-soluble NSF attachment protein 
NDUFA10 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10 
NDUFA11 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 
NDUFA12 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 
NDUFA13 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 
NDUFA2 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 
NDUFA3 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 
NDUFA4 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4 
NDUFA5 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 
NDUFA6 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 
NDUFA7 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 
NDUFA8 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 
NDUFB1 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 
NDUFB10 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 
NDUFB11 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11 
NDUFB3 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 
NDUFB4 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 
NDUFB5 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5 
NDUFB7 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 





NDUFB9 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 
NDUFC2 NADH dehydrogenase [ubiquinone] 1 subunit C2 
NDUFS1 NADH-ubiquinone oxidoreductase 75 kDa subunit 
NDUFS2 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 
NDUFS3 NADH dehydrogenase [ubiquinone] iron-sulfur protein 3 
NDUFS4 NADH dehydrogenase [ubiquinone] iron-sulfur protein 4 
NDUFS5 NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 
NDUFS7 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7 
NDUFS8 NADH dehydrogenase [ubiquinone] iron-sulfur protein 8 
NDUFV1 NADH dehydrogenase [ubiquinone] flavoprotein 1 
NDUFV2 NADH dehydrogenase [ubiquinone] flavoprotein 2 
NSF Vesicle-fusing ATPase 
OGDH 2-oxoglutarate dehydrogenase 
PFKL ATP-dependent 6-phosphofructokinase_ liver type 
PFKM ATP-dependent 6-phosphofructokinase_ muscle type 
PFKP ATP-dependent 6-phosphofructokinase_ platelet type 
PGAM1 Phosphoglycerate mutase 1 
PGAM2 Phosphoglycerate mutase 2 
PGK1 Phosphoglycerate kinase 1 
PGK2 Phosphoglycerate kinase 2 
PGLS 6-phosphogluconolactonase 
PGM1 Phosphoglucomutase-1 
PKM Pyruvate kinase 
PLP1 Myelin proteolipid protein 
PPA1 Inorganic pyrophosphatase 
PRPS2 Ribose-phosphate pyrophosphokinase 2 
PTPRB Receptor-type tyrosine-protein phosphatase beta 
RAB11B Ras-related protein Rab-11B  
RAB18 Ras-related protein Rab-18 
RAB21 Ras-related protein Rab-21 
RAB2A Ras-related protein Rab-2A 
RAB3A Ras-related protein Rab-3A 
RAB3B Ras-related protein Rab-3B 
RAB6B Ras-related protein Rab-6B 
RAB5C Ras-related protein Rab-5C 
SCOT Succinyl-CoA:3-ketoacid coenzyme A transferase 1 
SDHA Succinate dehydrogenase [ubiquinone] flavoprotein subunit 
SDHB Succinate dehydrogenase [ubiquinone] iron-sulfur subunit 
SDHC Succinate dehydrogenase cytochrome b560 subunit 
SLC12A2 Solute carrier family 12 member 2  
SLC4A4 Electrogenic sodium bicarbonate cotransporter 1 
SNAP25 Synaptosomal-associated protein 25 
STX1A Syntaxin-1A 
STX1B Syntaxin-1B 
STXBP1 Syntaxin-binding protein 1 
SUCLA2 Succinate--CoA ligase [ADP-forming] subunit beta 










TPI1 Triosephosphate isomerase 
UQCR10 Cytochrome b-c1 complex subunit 9 
UQCRB Cytochrome b-c1 complex subunit 7 
UQCRC1 Cytochrome b-c1 complex subunit 1 
UQCRC2 Cytochrome b-c1 complex subunit 2 
UQCRFS1 Cytochrome b-c1 complex subunit Rieske 
UQCRQ Cytochrome b-c1 complex subunit 8 
VAMP2 Vesicle-associated membrane protein 2 
VGLUT1 Vesicular glutamate transporter 1 
  
Gene  
Abca4 ATP binding cassette subfamily A member 4 
Atp1b1 ATPase Na+/K+ transporting subunitbBeta 1 
Atp2b2 ATPase plasma membrane Ca2+ transporting 2 
Cacng2 Calcium voltage-gated channel auxiliary subunit gamma 2 
Clic6 Chloride intracellular channel 6 
Folr1 Folate receptor 1 
Gabrr2 Gamma-aminobutyric acid type A receptor rho2 subunit 
Gria3 Glutamate ionotropic receptor AMPA type subunit 3 
Itpr1 Inositol 1,4,5-trisphosphate receptor type 1 
Kcnb1 Potassium voltage-gated channel subfamily B member 1 
Kcne2 Potassium voltage-gated channel subfamily E regulatory subunit 2 
Kcnj13 Potassium voltage-gated channel subfamily J member 13 
Kcnma1 Potassium calcium-activated channel subfamily M alpha 1 
Kcnq2 Potassium voltage-gated channel subfamily Q member 2 
Kcnt1 Potassium sodium-activated channel subfamily T member 1 
Pitpnm2 Phosphatidylinositol transfer protein membrane associated 2 
Sfxn2 Sideroflexin 2 
Slc13a4 Solute carrier family 13 member 4 
Slc24a4 Solute carrier family 23 member 4 
Slc29a4 Solute carrier family 29 member 4 
Slc4a5 Solute carrier family 4 member 5 
Slc5a3 Solute carrier family 5 member 3 
Steap2 STEAP2 metalloreductase 
Stra6 Stimulated by retinoic acid 6 
Ttr Transthyretin 
 
